
(
  (S
    (NP (NN Btk) (NN expression))
    (VP (VBZ is)
      (VP (VBN controlled)
        (PP (IN by)
          (NP
            (NP (NN Oct))
            (CC and)
            (NP (NN BOB.1/OBF.1))))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (S
      (NP (NN BOB.1/OBF.1))
      (VP (VBZ is)
        (NP (DT a) (JJ lymphocyte-restricted) (JJ transcriptional) (NN coactivator))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP
        (VP (VBZ binds)
          (PP
            (ADVP (RB together))
            (IN with)
            (NP (DT the)
              (NP (NN Oct1))
              (CC and)
              (NP (NN Oct2))
              (NP (NN transcription) (NNS factors))))
          (PP (TO to)
            (NP (NN DNA))))
        (CC and)
        (VP (VBZ enhances)
          (NP (PRP$ their) (NN transactivation) (NN potential)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Mice))
        (ADJP (JJ deficient)
          (PP (IN for)
            (NP (DT the) (JJ transcriptional) (NN coactivator) (NN BOB.1/OBF.1)))))
      (VP (VBP show)
        (NP
          (NP (JJ several) (NNS defects))
          (PP (IN in)
            (NP
              (NP
                (NP (NN differentiation))
                (, ,)
                (NP (NN function))
                (CC and)
                (NP (NN signaling)))
              (PP (IN of)
                (NP (NN B) (NNS cells))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN search))
          (PP (IN of)
            (NP (CD BOB.1/OBF.1) (JJ regulated) (NNS genes)))))
      (NP (PRP we))
      (VP (VBD identified)
        (NP
          (NP (CD Btk—a) (JJ cytoplasmic) (NN tyrosine) (NNS kinase—as))
          (NP
            (NP (DT a) (JJ direct) (NN target))
            (PP (IN of)
              (NP (NN BOB.1/OBF.1)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Analyses))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ human))
            (CONJP (RB as) (RB well) (IN as))
            (NP (JJ murine) (NN Btk) (NNS promoters)))))
      (VP (VBD revealed)
        (NP
          (NP (DT a) (JJ non-consensus) (NN octamer) (NN site))
          (ADJP (JJ close)
            (PP (TO to)
              (NP
                (NP (DT the) (NN start) (NN site))
                (PP (IN of)
                  (NP (NN transcription)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Here))
      (NP (PRP we))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN Oct) (NNS proteins))
              (PP
                (ADVP (RB together))
                (IN with)
                (NP (NN BOB.1/OBF.1))))
            (VP (VBP are)
              (ADJP (JJ able)
                (S
                  (VP (TO to)
                    (VP (VB form)
                      (NP
                        (NP (JJ ternary) (NNS complexes))
                        (PP (IN on)
                          (NP (DT these) (NNS sites))))
                      (ADVP
                        (ADVP (FW in) (FW vitro))
                        (CC and)
                        (ADVP (FW in) (FW vivo))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT This))
        (PP (IN in)
          (NP (NN turn))))
      (VP (VBZ leads)
        (PP (TO to)
          (NP
            (NP (DT the) (NN induction))
            (PP (IN of)
              (NP (NN Btk) (NN promoter) (NN activity)))
            (PP (IN in)
              (NP
                (NP (NN synergism))
                (PP (IN with)
                  (NP (DT the) (NN transcription) (NN factor) (NN PU.1)))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Btk))
      (, ,)
      (PP (IN like)
        (NP (NN BOB.1/OBF.1)))
      (, ,))))

(
  (S
    (S
      (VP (VBZ plays)
        (NP (DT a) (JJ critical) (NN role))
        (PP (IN in)
          (NP
            (NP (NN B) (NN cell) (NN development))
            (CC and)
            (NP (NN B) (NN cell) (NN receptor) (NN signalling))))))
    (. .)))

(
  (S
    (NP
      (NP (RB Therefore) (DT the) (NN down-regulation))
      (PP (IN of)
        (NP (NN Btk) (NN expression)))
      (PP (IN in)
        (NP (NN BOB.1/OBF.1-deficient))))))

(
  (S
    (NP (NN B) (NNS cells))
    (VP (MD could)
      (VP (VB be)
        (ADJP (JJ related)
          (PP (TO to)
            (NP
              (NP (DT the)
                (ADJP
                  (ADJP (JJ functional))
                  (CC and)
                  (ADJP (JJ developmental)))
                (NNS defects))
              (VP (VBN observed)
                (PP (IN in)
                  (NP (NN BOB.1/OBF.1-deficient)))))))))))

(
  (S
    (NP
      (NP (NNS mice))
      (. .))))

(
  (S
    (NP (NN INTRODUCTION))))

(
  (S
    (S
      (NP (DT The) (NN octamer) (NN motif) (NN ATGCAAAT))
      (VP (VBZ is)
        (ADJP (JJ important)
          (PP (IN for)
            (NP
              (ADJP (NN B) (JJ cell-specific))
              (NN gene) (NN regulation))))))
    (. .)))

(
  (S
    (SBAR (IN Although)
      (S
        (NP (PRP it))
        (VP (VBZ is)
          (ADVP (RB also))
          (VP (VBN found)
            (PP (IN in)
              (NP
                (NP (NNS promoters))
                (PP (IN of)
                  (NP
                    (NP
                      (ADJP (RB ubiquitously) (VBN expressed))
                      (NNS genes))
                    (PRN (-LRB- -LRB-)
                      (NP (NN 1–3))
                      (-RRB- -RRB-))))))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ critical) (NN element))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ regulatory) (NNS regions))
            (PP (IN of)
              (NP (JJ several)
                (ADJP (NN B) (JJ cell-specific))
                (VBN expressed) (NNS genes))))))
      (, ,)
      (PP (IN like)
        (NP
          (NP
            (NP (NN immunoglobulin) (NNS genes))
            (PRN (-LRB- -LRB-)
              (NP (NN 4,5))
              (-RRB- -RRB-)))
          (, ,)
          (NP
            (NP
              (NP (NN B29))
              (PRN (-LRB- -LRB-)
                (NP (NN Igβ))
                (-RRB- -RRB-)))
            (, ,)
            (NP (NN CD20))
            (CC and)
            (NP
              (NP (NN CD21))
              (PRN (-LRB- -LRB-)
                (NP (NN 6–8))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Detailed) (NNS analyses))
        (PP (IN of)
          (NP (DT the) (NN octamer) (NN sequence))))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP
              (NP (NNS mutations))
              (PP (IN in)
                (NP
                  (NP (JJ most) (NNS positions))
                  (PP (IN of)
                    (NP (DT the) (VBN conserved) (NN motif))))))
            (VP (VBP interfere)
              (PP (IN with)
                (NP
                  (NP (PRP$ its) (NN function))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 9))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN B) (NNS cells)))
      (, ,)
      (NP (CD two) (NN octamer) (NN transcription) (NNS factors))
      (VP (VBP bind)
        (PP (TO to)
          (NP
            (NP (DT the) (NN octamer) (NN element))
            (, ,)
            (NP (DT the)
              (ADJP (RB ubiquitously) (VBN expressed))
              (NN Oct1))
            (CC and)
            (NP
              (NP (DT the) (JJ lymphocyte-specific) (VBN expressed) (NN Oct2))
              (PRN (-LRB- -LRB-)
                (NP (CD 10))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (JJ B-cell-specific) (NN activity)))
      (NP (DT these) (NN transcription) (NNS factors))
      (VP (VBP need)
        (S
          (VP (TO to)
            (VP (VB interact)
              (PP (IN with)
                (NP
                  (NP (DT an) (JJ additional) (JJ lymphocyte-restricted) (NN coactivator))
                  (VP (VBN named)
                    (S
                      (NP
                        (NP (NN BOB.1/OBF.1))
                        (-LRB- -LRB-)
                        (NP
                          (NP (JJ alternative) (NNS names))
                          (VP (VBP are)
                            (NP (CD Bob.1))))))))))))))
    (, ,)))

(
  (S
    (NP
      (NP
        (NP
          (NP (NN OBF-1))
          (PRN (, ,)
            (NP (NN OCA-B))
            (-RRB- -RRB-)))
        (PRN (-LRB- -LRB-)
          (NP (NN 11,12))
          (-RRB- -RRB-)))
      (. .))))

(
  (S
    (S
      (NP (NN BOB.1/OBF.1))
      (VP
        (VP (VBZ displays)
          (NP
            (ADJP (RB only) (JJ weak))
            (NN DNA) (NN binding)))
        (CC and)
        (VP (VBZ is)
          (VP (VBN recruited)
            (PP (TO to)
              (NP (DT the) (NN octamer) (NN sequence)))
            (ADVP (RB predominantly))
            (PP (IN via)
              (NP
                (NP (NN interaction))
                (PP (IN of)
                  (NP (PRP$ its) (JJ N-terminal) (NN domain)))
                (PP (IN with)
                  (NP
                    (NP (DT the) (NNS POU-domains))
                    (PP (IN of)
                      (NP
                        (NP (NN Oct) (NNS factors))
                        (PRN (-LRB- -LRB-)
                          (NP (NN 11–19))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN transactivation) (NNS domains))
        (PP (IN of)
          (NP (CC both)
            (NP
              (NP (NN type))
              (PP (IN of)
                (NP (NN proteins—Oct))))
            (CC and)
            (NP
              (NP (NN BOB.1/OBF.1—act))
              (PP (IN in)
                (NP (NN synergy)))))))
      (VP (TO to)
        (VP (VB mediate)
          (NP (JJ octamer-dependent) (NN transcription)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN BOB.1/OBF.1) (NN protein) (NN isoform))
        (VP (VBG bearing)
          (NP (DT an) (JJ N-terminal) (VBN myristoylated) (NN extension))))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN localized)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN membrane) (NN fraction))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 20))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN function))
        (PP (IN of)
          (NP (DT this) (NN isoform))))
      (VP (VBZ is) (RB not)
        (VP (VBN understood)
          (ADVP (RB yet)))))
    (. .)))

(
  (S
    (S
      (NP (NN Gene) (NN targeting) (NNS experiments))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (NN BOB.1/OBF.1))
            (VP (VBZ is)
              (ADJP (JJ important))
              (PP (IN at)
                (NP
                  (NP (JJ several) (NNS stages))
                  (PP (IN of)
                    (NP
                      (NP (NN B) (NN cell) (NN development))
                      (PP
                        (PP (IN in)
                          (NP (DT the) (NN bone) (NN marrow)))
                        (CONJP (RB as) (RB well) (IN as))
                        (PP (IN in)
                          (NP (JJ peripheral) (JJ secondary) (JJ lymphoid) (NNS tissues)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In)
          (NP (DT the) (NN bone) (NN marrow)))
        (NP
          (NP (DT the) (NN number))
          (PP (IN of)
            (NP
              (ADJP
                (ADJP (JJ immature))
                (CONJP (RB as) (RB well))
                (ADJP (JJ transitional)))
              (NN B) (NNS cells))))
        (VP (VBZ is)
          (VP (VBN reduced))))
      (CC and)
      (S
        (NP (JJR fewer) (NNS cells))
        (VP (VBP reach)
          (NP (DT the) (NN periphery) (-LRB- -LRB-) (CD 21) (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP (NN BOB.1/OBF.1))
      (VP (VBZ is)
        (VP (VBN expressed)
          (PP (IN throughout)
            (NP (NN B) (NN cell) (NN ontogeny)))
          (, ,)
          (PP (IN albeit)
            (PP (IN at)
              (NP (JJ different) (NNS levels)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJS highest) (NN expression))
      (VP (VBZ is)
        (VP (VBN found)
          (PP (IN in)
            (NP
              (NP (JJ germinal) (NN center) (NN B) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NN 22,23))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The)
        (ADJP (RBS most) (JJ striking))
        (NN characteristic))
      (PP (IN of)
        (NP (NN BOB.1/OBF.1−/−))))))

(
  (S
    (S
      (NP (NNS mice))
      (VP (VBZ is)
        (NP (DT the) (JJ complete) (NN failure)
          (S
            (VP (TO to)
              (VP (VB form)
                (NP
                  (NP (JJ germinal) (NNS centers))
                  (PP (IN in)
                    (NP
                      (NP (NN spleen))
                      (CC and)
                      (NP
                        (NP (NN lymph) (NNS nodes))
                        (PRN (-LRB- -LRB-)
                          (NP (NN 24–26))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (DT the) (NN production))
        (PP (IN of)
          (NP (VBN switched) (NN immunoglobulin) (NNS isotypes))))
      (VP (VBZ is)
        (ADVP (RB strongly))
        (VP (VBN reduced))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (DT the) (NN development))
      (PP (IN of)
        (NP (DT the) (JJ marginal) (NN zone) (NN B) (NN cell) (NN compartment)))
      (PP (IN in)
        (NP (NN BOB.1/OBF.1−/−))))))

(
  (S
    (S
      (NP (NNS mice))
      (VP (VBZ is)
        (ADVP (RB severely))
        (VP (VBN affected)
          (PRN (-LRB- -LRB-)
            (NP (CD 27))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (JJ B-cell-specific) (NN expression))
      (PP (IN of)
        (NP (DT a) (NN bcl2-transgene))))
    (VP (MD can)
      (VP (VB rescue)
        (NP
          (NP (JJ several) (NNS aspects))
          (PP (IN of)
            (NP (JJ early) (NN lymphopoiesis)))
          (PP (IN in)
            (NP (NNS BOB.1/OBF.1−/−))))))))

(
  (S
    (NP
      (NP (NNS mice))
      (. .))))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (JJ terminal) (NN differentiation))
        (CC and)
        (NP (JJ specific) (NN B) (NN cell) (NNS responses)))
      (VP (VBP are)
        (ADVP (RB still))
        (ADJP (JJ defective))
        (PRN (-LRB- -LRB-)
          (NP (CD 28))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (NN BOB.1/OBF.1))
      (VP (VBZ is)
        (ADVP (RB also) (JJ inducible))
        (VP (VBN expressed)
          (PP (IN in)
            (NP
              (NP (NN T) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NN 29,30))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ critical) (NN function))
        (PP (IN in)
          (NP (NN T) (NNS cells))))
      (VP (VBZ has)
        (ADVP (RB however))
        (RB not)
        (VP (VBN been)
          (VP (VBN identified)
            (ADVP (RB yet))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT Some))
        (PP (IN of)
          (NP
            (NP (DT the) (NNS defects))
            (PP (IN in)
              (NP
                (NP
                  (ADJP
                    (ADJP (JJ early))
                    (CC and)
                    (ADJP (JJ late)))
                  (NN B) (NN cell) (NN development))
                (CONJP (RB as) (RB well) (IN as))
                (NP (FW in) (NN B) (NN cell) (NN function)))))))
      (VP (VBD were)
        (NP
          (NP (NN reminiscent))
          (PP (IN of)
            (NP
              (NP (NNS defects))
              (PP (IN in)
                (NP
                  (NP (NNS mice))
                  (ADJP (JJ deficient)
                    (PP (IN of)
                      (NP
                        (NP (JJ functional) (NN Bruton) (POS 's) (NN tyrosine) (NN kinase))
                        (PRN (-LRB- -LRB-)
                          (NP (NN Btk))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Mutations))
        (PP (IN in)
          (NP
            (NP (DT the) (NN gene))
            (VP (VBG coding)
              (PP (IN for)
                (NP (NN Btk)))))))
      (VP (VBP cause)
        (NP
          (NP
            (NP
              (NP (JJ X-linked) (NN agammaglobulinemia))
              (PRN (-LRB- -LRB-)
                (NP (NN XLA))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP
                (NP
                  (NP (NNS humans))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 31))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (JJ X-linked) (NN immunodeficiency))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Xid))
                    (-RRB- -RRB-)))))
            (PP (IN in)
              (NP
                (NP (NNS mice))
                (VP (VBN -LSB-reviewed)
                  (PP (IN in)
                    (NP (NN Ref))))))
            (. .))
          (PRN (-LRB- -LRB-)
            (NP (CD 32))
            (-RRB- -RRB-))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ Xid) (NN phenotype))
      (VP (VBZ is)
        (VP (VBN characterized)
          (PP
            (PP (IN by)
              (NP
                (NP (DT a) (NN defect))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN transition))
                    (PP (IN from)
                      (NP (DT the) (NN pre-B)))
                    (PP (TO to)
                      (NP (JJ immature) (NN B) (NNS cells)))))
                (PP (IN in)
                  (NP (DT the) (NN bone) (NN marrow)))))
            (CONJP (RB as) (RB well) (IN as))
            (PP (IN by)
              (NP
                (NP (DT a) (VBN reduced) (NN number))
                (PP (IN of)
                  (NP
                    (NP (JJ peripheral) (NN B) (NNS cells))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBP exhibit)
                          (NP
                            (NP (DT an) (JJ immature) (NN phenotype))
                            (PRN (-LRB- -LRB-)
                              (NP (NN 33–35))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP (DT the) (NN B-1) (NN cell) (NN compartment))
      (VP (VBZ is)
        (ADJP (JJ absent)
          (PP (IN in)
            (NP (NN Xid-mice))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Consequently))
      (, ,)
      (NP
        (NP (DT the) (NNS levels))
        (PP (IN of)
          (NP (NN serum)
            (NP
              (NP (NN IgM))
              (CC and)
              (NP (NN IgG3))))))
      (VP (VBP are)
        (ADJP (JJ low))))
    (. .)))

(
  (S
    (ADJP (JJ Similar)
      (PP (TO to)
        (NP (NN BOB.1/OBF.1−/−))))))

(
  (S
    (NP
      (NP
        (NP (NNS animals))
        (PRN (-LRB- -LRB-)
          (NP (NN 25,27))
          (-RRB- -RRB-)))
      (, ,)
      (NP
        (NP (NNS mice))
        (ADJP (JJ deficient)
          (PP (IN for)
            (NP
              (NP
                (NP (DT an) (JJ functional) (NN Btk))
                (VP (VBP show)
                  (NP
                    (NP (JJ severe) (NNS defects))
                    (PP (IN in)
                      (NP (NN B) (NN cell) (NN receptor) (NN signaling))))))
              (, ,)
              (VP (VBN expressed)
                (PP (IN by)
                  (NP
                    (NP (VBN reduced) (NN tyrosine) (NN phosphorylation))
                    (ADJP (JJ -LSB-reviewed)
                      (PP (IN in)
                        (NP (-LRB- -LRB-) (CD 32) (-RRB- -RRB-)))))))
              (-RRB- -RSB-)))))
      (, ,))
    (VP
      (VP (VBD reduced)
        (NP
          (NP (NN elevation))
          (PP (IN of)
            (NP (JJ intracellular) (NN Ca2+) (NNS levels))))
        (PRN (-LRB- -LRB-)
          (NP (CD 36))
          (-RRB- -RRB-)))
      (, ,)
      (VP (VBD reduced)
        (NP
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP
                (NP (NN NF-κB))
                (PRN (-LRB- -LRB-)
                  (NP (NN 37,38))
                  (-RRB- -RRB-)))))
          (CONJP (RB as) (RB well) (IN as))
          (NP (JJ impaired) (NN proliferation)))
        (PP (IN upon)
          (NP
            (NP (NN IgM) (NN crosslinking))
            (PRN (-LRB- -LRB-)
              (NP (NN 33,34))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (PP (VBN Based)
        (PP (IN on)
          (NP (DT these) (NNS findings))))
      (NP (PRP one))
      (VP (MD may)
        (VP (VB suggest)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN BOB.1/OBF.1))
                (CC and)
                (NP (NN Btk)))
              (VP (VBP have)
                (NP (VBG overlapping) (NNS functions))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (NNS mice))
        (ADJP (JJ mutant)
          (PP (IN for)
            (NP (DT both) (NNS proteins)))))
      (ADVP (RB almost) (RB completely))
      (VP
        (VP (VBP lack)
          (NP (JJ peripheral) (NN B) (NNS cells)))
        (CC and)
        (VP (VBP show)
          (NP
            (NP
              (NP (DT a) (JJ severe) (NN agammaglobulinemia))
              (PRN (-LRB- -LRB-)
                (NP (CD 39))
                (-RRB- -RRB-)))
            (, ,)
            (NP
              (NP (DT a) (NN phenotype))
              (VP (VBG resembling)
                (NP
                  (NP (JJ human) (NNS XLA))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 31))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (SBAR (IN although)
        (S
          (NP
            (NP (NN BOB.1/OBF.1))
            (CC and)
            (NP (NN Btk)))
          (VP (VBP share)
            (NP (DT some) (VBG overlapping) (NNS functions)))))
      (, ,)
      (NP (PRP they))
      (VP (VBP are)
        (ADVP (RB also))
        (VP (VBN involved)
          (PP (IN in)
            (NP
              (NP (JJ distinct) (NN signaling) (NNS pathways))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBP are)
                    (ADJP (JJ important)
                      (PP (IN for)
                        (NP
                          (NP (NN B) (NN cell) (NN development))
                          (CC and)
                          (NP (NN function)))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB get)
            (NP
              (NP (NNS insights))
              (PP (IN into)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP (NN Btk) (NN expression)))))))))
      (NP (DT the)
        (ADJP
          (ADJP (JJ human))
          (PRN (-LRB- -LRB-)
            (NP (NN 40,41))
            (-RRB- -RRB-))
          (CC and)
          (ADJP (JJ murine))
          (PRN (-LRB- -LRB-)
            (NP (NN 42,43))
            (-RRB- -RRB-)))
        (NN promoter) (NNS regions))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN for)
            (NP
              (NP (JJ conserved) (JJ regulatory) (NNS elements))
              (PRN (-LRB- -LRB-)
                (NP (NN 44–49))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Recently))
      (, ,)
      (NP
        (NP (JJ regulatory) (NNS elements))
        (ADJP (JJ necessary)
          (PP (IN for)
            (NP (NN Btk) (NN gene) (NN activation)))))
      (VP (VBD were)
        (ADVP (RB also))
        (VP (VBN identified)
          (PP (IN in)
            (NP (NN intron1))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN btk) (NN promoter))
      (VP (VBZ does) (RB not)
        (VP (VB contain)
          (NP (DT an) (JJ obvious) (NN TATA) (NN box)))))
    (. .)))

(
  (S
    (S
      (NP (NN Transcription))
      (VP (VBZ is)
        (VP (VBN initiated)
          (PP (IN at)
            (NP (DT a) (JJ putative) (NN initiator) (NN element))))))
    (. .)))

(
  (S
    (S
      (NP (NN Deletion) (NNS analyses))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT a) (NN sequence))
              (PP (IN of)
                (NP
                  (NP (CD 280) (NN bp))
                  (ADVP (RB upstream)
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NN start) (NN site))
                        (PP (IN of)
                          (NP (NN transcription)))))))))
            (VP (VBZ is)
              (ADJP (JJ sufficient)
                (PP (IN for)
                  (NP
                    (NP (DT the) (JJ cell-type-specific) (NN regulation))
                    (PP (IN of)
                      (NP (NN Btk) (NN expression)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN transcription) (NNS factors)
        (NP
          (NP (NN Sp1))
          (, ,)
          (NP (NN Sp3))
          (, ,)
          (NP (NN Spi-B))
          (CC and)
          (NP (NN PU.1))))
      (VP (VBP are)
        (ADJP (JJ able)
          (S
            (VP (TO to)
              (ADVP (RB synergistically))
              (VP (VB activate)
                (NP (DT the) (NN Btk) (NN promoter))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (PP (IN in)
        (NP
          (NP
            (NP (JJ PU.1-deficient) (JJ fetal) (NN liver) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (CD 48))
              (-RRB- -RRB-)))
          (CONJP (RB as) (RB well) (IN as))
          (NP
            (NP (JJ SP1−/−) (JJ embryonic) (NN stem) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (CD 49))
              (-RRB- -RRB-)))))
      (, ,)
      (NP (NN Btk) (NN expression))
      (VP
        (VP (VBD was)
          (ADJP (CC either)
            (ADJP (VBN reduced))
            (CC or)
            (ADJP (RB not) (VBN affected))))
        (CC but)
        (RB not)
        (VP (VBN abolished))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ indicates)
        (SBAR (IN that)
          (S
            (NP
              (ADJP
                (ADJP (JJ additional))
                (, ,)
                (CC yet)
                (ADJP (RB not) (VBN identified)))
              (NNS factors))
            (ADVP (RB also))
            (VP (VBP contribute)
              (PP (TO to)
                (NP (NN Btk) (NN promoter) (NN activity))))))))
    (. .)))

(
  (S
    (ADVP (RB Here))
    (NP (PRP we))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP (DT the) (NN transcription) (NNS factors)
            (NP
              (NP (NN Oct1))
              (CC and)
              (NP (NN Oct2))))
          (VP (VBP are)
            (ADJP (JJ able)
              (S
                (VP (TO to)
                  (VP (VB bind)
                    (PP (IN in)
                      (NP
                        (NP (NN concert))
                        (PP (IN with)
                          (NP (DT the) (NN coactivator) (NN BOB.1/OBF.1)))))
                    (PP (TO to)
                      (NP
                        (NP (DT a) (JJ non-perfect) (NN octamer) (NN site))
                        (PP (IN within)
                          (NP
                            (NP (DT the)
                              (ADJP
                                (ADJP (JJ human))
                                (CC and)
                                (ADJP (JJ murine)))
                              (NN Btk) (NNS promoters))
                            (VP (VBG leading)
                              (PP (TO to)
                                (NP (PRP$ their) (NN activation))))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Moreover))
      (, ,)
      (NP
        (NP
          (NP (NN Oct))
          (CC and)
          (NP (NN BOB.1/OBF.1)))
        (NNS proteins))
      (VP (VBP activate)
        (NP (DT the) (JJ murine) (NN Btk) (NN promoter))
        (ADVP (RB synergistically))
        (PP (IN with)
          (NP (NN PU.1)))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (NN importance))
      (PP (IN of)
        (NP (DT the) (NN Oct/BOB.1/OBF.1-mediated))))))

(
  (S
    (NP (NN btk) (NN gene) (NN activation))
    (VP (VBZ is)
      (VP (VBN underlined)
        (PP (IN by)
          (NP
            (NP (DT the) (NN fact))
            (WHNP (WDT that))
            (PP (IN in)
              (NP (NN BOB.1/OBF.1-deficient)))))))))

(
  (S
    (S
      (NP
        (NP
          (NP (NN B) (NNS cells))
          (NN expression))
        (PP (IN of)
          (NP (NN Btk))))
      (VP (VBZ is)
        (VP (VBN impaired))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (PRP we))
      (VP (VBD identified)
        (NP
          (NP (DT the) (JJ non-perfect) (NN octamer) (NN site))
          (ADJP (JJ present)
            (PP (IN in)
              (NP
                (NP
                  (ADJP (JJ human)))
                (CONJP (RB as) (RB well) (IN in))
                (NP (DT the) (JJ murine) (NN Btk) (NN promoter))))))
        (PP (IN as)
          (NP
            (NP (DT a) (VBN conserved) (JJ regulatory) (NN site))
            (ADJP (JJ important)
              (PP (IN for)
                (NP
                  (ADJP (NN B) (JJ cell-specific))
                  (NN btk) (NN gene) (NN regulation))))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS MATERIALS))
      (CC AND)
      (NP (NNS METHODS)))))

(
  (S
    (NP
      (NP (NN C57BL/6) (JJ wild) (NN type))
      (CC and)
      (NP (NN BOB.1/OBF.1−/−)))))

(
  (S
    (NP
      (NP
        (NP (NNS mice))
        (PP (IN on)
          (NP (DT the) (JJ same) (JJ genetic) (NN background))))
      (CONJP (RB as) (RB well) (IN as))
      (NP (DT the) (NNS 1.5/B.1−/−)))))

(
  (S
    (S
      (NP (NNS mice))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN from)
            (NP (PRP$ our) (JJ breeding) (NN facility))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Mice))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP
            (NP (CD 8–12) (NNS weeks))
            (IN after)
            (NP (NN birth))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN generation))
        (PP (IN of)
          (NP (NNS mice))))
      (VP (VBZ 1.5/B.1−/−)))
    (. ,)))

(
  (S
    (S
      (S
        (ADJP (JJ transgenic)
          (PP (IN for)
            (NP
              (NP (NN µE-tTa))
              (CC and)
              (NP (NN tetO-BOB.1/OBF.1))))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN described)
            (PRN (-LRB- -LRB-)
              (NP (CD 21))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (VP
          (VP
            (VP (VBN labeled)
              (PP (IN with)
                (NP (DT an) (NN anti-B220-biotin-antibody))))
            (CC and)
            (VP (VBN revealed)
              (PP (IN by)
                (NP (NN Streptavidin-Cy-Chrom)))))
          (CC and)
          (VP
            (ADVP (RB subsequently))
            (VBN sorted)
            (PP (IN with)
              (NP
                (NP (DT a)
                  (NP (NN FACSORT))
                  (CC plus)
                  (NP (NN cytometer)))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Becton) (NNP Dickinson))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Stainings))
      (VP (VBD were)
        (VP (VBN performed)
          (PP (IN in)
            (NP
              (NP (NNS PBS))
              (VP (VBG containing)
                (NP
                  (NP
                    (NP (CD 0.1) (NN %) (NN BSA))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NN Roche) (NN Diagnostics))
                        (, ,)
                        (NP (NNP Mannheim) (, ,) (NNP GER)))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (ADJP (CD 0.1) (NN %))
                    (NN Na-azid))
                  (CC and)
                  (NP
                    (NP (JJ saturating) (NNS concentrations))
                    (PP (IN of)
                      (NP (NN anti-CD16/CD32))))))))
          (S
            (VP (TO to)
              (VP (VB block)
                (NP (NN FcγIII/II) (NNS receptors))))))))
    (. .)))

(
  (S
    (S
      (NP (DT All) (NNS antibodies))
      (VP (VBD were)
        (VP (VBN purchased)
          (PP (IN from)
            (NP (NNP Becton) (NNP Dickinson))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (JJ Single) (NN cell) (NNS suspensions))
          (PP (IN from)
            (NP (NN mouse) (NNS splenocytes))))
        (VP (VBD were)
          (VP (VBN incubated)
            (PP (IN with)
              (NP
                (NP (NNS antibodies))
                (PP (IN against)
                  (NP
                    (NP
                      (NP (NN CD4))
                      (, ,)
                      (NP (NN CD8)))
                    (-LRB- -LRB-)
                    (VP (VBN derived)
                      (PP (IN from)
                        (NP (DT an) (JJ antibody-producing) (NN hybridoma) (NN cell) (NN line))))
                    (-RRB- -RRB-))))))))
      (CC and)
      (S
        (NP (JJ positive) (NNS cells))
        (VP (VBD were)
          (VP (VBN eliminated)
            (PP (IN by)
              (NP
                (NP (NN complement) (NN lysis))
                (VP (VBG using)
                  (NP
                    (NP (NN baby) (NN rabbit) (NN complement))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Cedarlane))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN treatment))
      (VP (VBD was)
        (VP (VBN followed)
          (PP (IN by)
            (NP
              (NP
                (NP (DT a) (JJ lympholyte) (NN M) (NN gradient))
                (PRN (-LRB- -LRB-)
                  (NP (NN Cedarlane))
                  (-RRB- -RRB-)))
              (S
                (VP (TO to)
                  (VP (VB eliminate)
                    (NP (JJ red) (NN blood)
                      (CONJP (RB as) (RB well) (IN as))
                      (JJ dead) (NNS cells))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN purity))
        (PP (IN of)
          (NP (DT the) (NN B220+) (NN B) (NN cell) (NN population))))
      (VP (VBD was)
        (NP (CD >95) (NN %))))
    (. .)))

(
  (S
    (S
      (NP (NN NIH/3T3)
        (CC and)
        (NN HeLa) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN cultured)
            (PP (IN in)
              (NP
                (NP
                  (NP (NN DMEM))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN Life) (NNS Technologies))
                      (, ,)
                      (NP (NNP Inc.)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP (NN BJAB)
                    (CC and)
                    (NN S194) (NNS cells))
                  (PP (IN in)
                    (NP
                      (NP
                        (NP (NN RPMI))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN Life) (NNS Technologies))
                            (, ,)
                            (NP (NNP Inc.)))
                          (-RRB- -RRB-)))
                      (VP (VBN supplemented)
                        (PP (CC both)
                          (IN with)
                          (NP
                            (NP
                              (ADJP (CD 10) (NN %))
                              (NN FCS))
                            (, ,)
                            (NP (NNS antibiotics))
                            (CC and)
                            (NP
                              (ADJP (CD 50) (NN µM))
                              (NN β-ME))))))))
                (, ,))))
          (CC and)
          (VP (VBN grown)
            (PP (IN at)
              (NP
                (NP (NN 37°C))
                (CC and)
                (NP
                  (ADJP (CD 5) (NN %))
                  (NN CO2))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Transfections))
        (PP (IN of)
          (NP (NN NIH/3T3) (NNS cells))))
      (VP (VBD were)
        (VP (VBN performed)
          (PP (IN by)
            (NP (NN electroporation)))
          (PRN (-LRB- -LRB-)
            (NP (JJ Bio-Rad))
            (-RRB- -RRB-))
          (PP (IN with)
            (NP
              (NP (CD 450) (NN V)
                (CC and)
                (CD 250) (NN µF))
              (PP (IN in)
                (NP (NN phosphate) (JJ buffered) (NN saline))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Pre-B) (NN cell) (NNS lines))
      (VP (VBD were)
        (VP (VBN established)
          (PP (IN by)
            (S
              (VP (VBG culturing)
                (NP
                  (NP (NN bone) (NN marrow) (NNS cells))
                  (PP (IN from)
                    (NP
                      (NP (NNS mice))
                      (PP (IN of)
                        (NP (DT the) (VBN indicated) (NN genotype))))))
                (PP (IN under)
                  (NP
                    (NP (DT the) (JJ stimulatory) (NN influence))
                    (PP (IN of)
                      (NP (JJ irradiated) (JJ adherent) (JJ stromal) (NNS cells)
                        (NP
                          (NP (NN ST2))
                          (CC and)
                          (NP (DT the) (NN cytokine) (NN IL-7)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ As) (NN culture) (NN medium))
      (VP (VBD was)
        (VP (VBN used)
          (NP
            (NP
              (NP (NN IMDM))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN Life) (NNS Technologies))
                  (, ,)
                  (NP (NNP Inc.)))
                (-RRB- -RRB-)))
            (VP (VBN supplemented)
              (PP (IN with)
                (NP
                  (NP
                    (ADJP (CD 5) (NN %))
                    (NN FCS))
                  (, ,)
                  (NP (NNS antibiotics))
                  (, ,)
                  (NP
                    (ADJP (CD 50) (NN µM))
                    (NN β-ME))
                  (, ,)
                  (NP
                    (NP
                      (NP
                        (ADJP (CD 2) (NN %))
                        (NN supernatant))
                      (PP (IN from)
                        (NP (NN IL-7) (NN producing) (NNS cells))))
                    (NP (NN J558) (-LRB- -LRB-) (NN A))))))))))
    (. .)))

(
  (S
    (NP
      (NP
        (NP
          (NP (NNP Rolink))
          (PRN (, ,)
            (NP (NNP Basel))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP
            (ADJP (CD 5) (NN %))
            (NP (NNP Primatone)))
          (PRN (-LRB- -LRB-)
            (S
              (NP (NN PAN) (NNS Systems))
              (NP (NNP GmbH)))
            (-RRB- -RRB-))))
      (. .))))

(
  (S
    (S
      (NP (NNS Cells))
      (VP (VBD were)
        (VP (VBN grown)
          (PP (IN at)
            (NP
              (NP (NN 37°C))
              (CC and)
              (NP
                (ADJP (CD 10) (NN %))
                (NN CO2)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ murine) (NN Btk) (NN promotor))
        (PRN (-LRB- -LRB-)
          (NP (CD −436) (TO to) (CD +79))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN cloned)
          (PP (IN into)
            (NP
              (NP (DT the) (NN pTKL/2) (NN vector))
              (VP (VBG containing)
                (NP
                  (NP (DT the) (JJ HSV-thymidine) (NN kinase) (NN promoter))
                  (PRN (-LRB- -LRB-)
                    (NP (CD −105) (TO to) (CD +52))
                    (-RRB- -RRB-)))
                (PP (IN from)
                  (NP
                    (NP (DT the) (NN pBLCAT2))
                    (PP (IN in)
                      (NP
                        (NP (NN front))
                        (PP (IN of)
                          (NP
                            (NP (DT the) (JJ firefly) (NN luciferase))
                            (NN coding) (NN region)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN HSV-thymidine) (NN kinase) (NN promoter))
      (VP (VBD was)
        (VP
          (VP (VBN excised)
            (PP (IN by)
              (NP
                (NP (DT a) (NN restriction) (NN endonuclease) (NN digest))
                (VP (VBG using)
                  (NP
                    (NP (NN HindIII))
                    (CC and)
                    (NP (NN BglII)))))))
          (CC and)
          (VP (VBN replaced)
            (PP (IN by)
              (NP
                (NP (DT the) (NN Btk) (NN promoter))
                (VP (VBN cloned)
                  (PP (IN via)
                    (NP
                      (NP (JJ genomic) (NN PCR))
                      (VP (VBG using)
                        (NP (DT the) (VBG following) (NNS primers))))))))))))
    (: :)
    (NP
      (NP (NN mBtkpr-HindIII))
      (: :)
      (NP (NN GAG) (NN TAA) (NN GCT) (NN TTC) (NN TTT) (NN GTC) (NN TGT) (NN CCT) (NN CC))
      (: ;)
      (NP (NN mBtkprom-BglII))
      (: :)
      (NP (NN TGA) (NN GAT) (NN GCC) (NN AGA) (NN TCT) (NN TGG) (NN AAG) (NN GTG)))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ mutant) (NN Btk) (NN promoter))
      (VP (VBD was)
        (VP (VBN created)
          (PP (IN by)
            (NP
              (NP (JJ site-directed)
                (ADJP (FW in) (FW vitro))
                (NN mutagenesis))
              (PRN (-LRB- -LRB-)
                (NP (NN Stratagene))
                (-RRB- -RRB-))))
          (S
            (VP (VBG using)
              (NP
                (NP (DT the) (VBG following) (NNS primers))
                (: :)
                (NP (NN mBTKprom) (CD 3M)
                  (NP (CD 5) ('' ')))
                (: :)
                (NP
                  (NP (NN GTA) (NN AAG) (NN AGG))
                  (NP (NN TCC) (NN CAG) (NN TAC) (NN AAT) (NN GTC) (NN GGG) (NN GGG) (NN TGG))
                  (: ;)
                  (NP
                    (NP (NN mBTKprom) (CD 3M))
                    (CD 3) ('' ')))
                (: :)
                (NP (NN CCA) (NN CCC) (NN CCC) (NN GAC) (NN ATT) (NN GTA) (NN CTG) (NN GGA) (NN CCT) (NN CTT) (NN TAC))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ wild-type) (NN BOB.1/OBF.1) (NN cDNA))
      (VP (VBD was)
        (VP (VBN cloned)
          (PP (IN into)
            (NP (DT the) (NN expression) (NN vector) (NN pcDNA3))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN cloning))
        (PP (IN of)
          (NP (DT the)
            (NP (NN Oct2))
            (CC and)
            (NP (NN PU.1))
            (NP (NN expression) (NNS vectors)))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN described)
            (PRN (-LRB- -LRB-)
              (NP (NN 50,51))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP
          (NP
            (ADJP (FW in) (FW vitro))
            (NN translation))
          (PP (IN of)
            (NP (NN BOB.1/OBF.1)))))
      (NP (DT the) (JJ pMT/PKA-Bob) (NN expression) (NN vector))
      (VP (VBD was)
        (VP (VBN used)))
      (PRN (-LRB- -LRB-)
        (NP (CD 15))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (S
      (NP (NNS Proteins))
      (VP (VBD were)
        (VP (VBN prepared)
          (S
            (VP (VBG using)
              (NP
                (NP (NN lysis) (NN buffer))
                (VP (VBG containing)
                  (NP
                    (NP
                      (ADJP (CD 20) (NN mM))
                      (NN Tris))
                    (NP (NN pH) (CD 7.5))
                    (, ,)
                    (NP
                      (ADJP (CD 1) (NN mM))
                      (NN EDTA))
                    (, ,)
                    (NP
                      (ADJP (CD 100) (NN mM))
                      (NN NaCl))
                    (, ,)
                    (NP
                      (ADJP (CD 1) (NN %))
                      (NN Triton) (NN X-100))
                    (, ,)
                    (NP
                      (ADJP (CD 0.5) (NN %))
                      (NN sodiumdeoxycholat))
                    (CC and)
                    (NP
                      (ADJP (CD 0.1) (NN %))
                      (NN SDS))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Proteins))
      (VP (VBD were)
        (VP
          (VP (VBN resolved)
            (PP (IN on)
              (NP (DT a)
                (ADJP (CD 12.5) (NN %))
                (NN SDS–PAGE))))
          (CC and)
          (VP (VBN transferred)
            (PP (TO to)
              (NP
                (NP (NN PVDF) (NN membrane))
                (PRN (-LRB- -LRB-)
                  (NP (NN Millipore))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP
          (NP (NN immunodetection))
          (PP (IN of)
            (NP (NN Btk)))))
      (NP (DT a) (JJ polyclonal) (NN anti-Btk) (NN antibody))
      (VP (VBD was)
        (VP (VBN used)
          (PRN (-LRB- -LRB-)
            (NP (NN BD))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP
          (NP (NN detection))
          (PP (IN of)
            (NP (NN Rel-A)))))
      (NP
        (NP (DT a) (JJ Rel-A-specific) (JJ polyclonal) (NN antibody))
        (PRN (-LRB- -LRB-)
          (NP (NNP Santa) (NNP Cruz) (NN Biotechnology))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN purchased))))
    (. .)))

(
  (S
    (S
      (NP (NNS Proteins))
      (VP (VBD were)
        (VP (VBN visualized)
          (S
            (VP (VBG using)
              (NP
                (NP
                  (NP
                    (NP
                      (NP
                        (ADJP
                          (ADJP (JJ anti-mouse))
                          (CC or)
                          (ADJP (JJ anti-rabbit)))
                        (NN horseradish) (NN peroxidase))
                      (VBN conjugated) (NNS antibodies))
                    (, ,)
                    (ADVP (RB respectively)))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Pierce))
                    (-RRB- -RRB-)))
                (CC and)
                (NP
                  (NP (DT the) (NN ECL) (NN detection) (NN system))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Amersham))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Total) (NN RNA))
      (VP (VBD was)
        (VP (VBN prepared)
          (S
            (VP (VBG using)
              (NP
                (NP
                  (NP (DT the) (JJ Trizol®-reagent))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN Life) (NNS Technologies))
                      (, ,)
                      (NP (NNP Inc.)))
                    (-RRB- -RRB-)))
                (VP (VBG according)
                  (PP (TO to)
                    (NP
                      (NP (DT the) (NN protocol))
                      (PP (IN of)
                        (NP (DT the) (NN manufacturer))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN After)
        (NP
          (NP (NN separation))
          (PP (IN of)
            (NP (NNS RNAs)))
          (PP (IN on)
            (NP (DT a)
              (ADJP (CD 1) (NN %))
              (NN formaldehyde) (NN agarose) (NN gel)))))
      (, ,)
      (NP (NN northern) (NN blot) (NNS analyses))
      (VP (VBD were)
        (VP (VBN performed)
          (SBAR (IN as)
            (S
              (VP (VBN described)
                (PP (IN in)
                  (NP (NN Ref))))))))
      (. .))
    (PRN (-LRB- -LRB-)
      (NP (CD 52))
      (-RRB- -RRB-))))

(
  (S
    (S
      (NP
        (NP
          (NP (NN Preparation))
          (PP (IN of)
            (NP
              (NP (JJ whole) (NN cell) (NNS extracts))
              (PP (IN for)
                (NP
                  (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay))
                  (PRN (-LRB- -LRB-)
                    (NP (NN EMSA))
                    (-RRB- -RRB-)))))))
        (CC and)
        (NP
          (NP (DT the) (NN protocol))
          (PP (IN of)
            (NP (DT the) (NN EMSA) (NN procedure)))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN described)
            (ADVP (RBR earlier))
            (PRN (-LRB- -LRB-)
              (NP (NN 53,54))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S (IN For) (NN EMSA) (, ,) (DT the) (VBG following) (NNS oligonucleotides) (VBD were) (VBN annealed)
    (CC and)
    (RB subsequently) (VBN labeled) (VBG using) (NN P32) (NN αdCTP) (IN in) (DT a) (JJ fill-in) (NN reaction) (: :) (NN mBtkprom) (NN 5′-gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AGG) (NN CAA) (NN ATG) (NN TCG) (NN GGG) (NN GG) (, ,) (NN mBtk) (NN prom) (NN 3′-gcgg) (NN CCC) (NN CCC) (NN GAC) (NN ATT) (NN TGC) (NN CTG) (NN GGA) (NN CCT) (NN CT) (: ;) (NN hBtkprom) (NN 5′) (NN gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AAG) (NN CAA) (NN ATG) (NN AAG) (NN GGC) (NN GG) (, ,) (NN hBtkprom) (NN 3′-ggcg) (NN CCG) (NN CCC) (NN TTC) (NN ATT) (NN TGC) (NN TTG) (NN GGA) (NN CCT) (NN CT) (: ;) (JJ mBtkprom-Mut) (NN 5′-gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AGT) (NN ACA) (NN ATG) (NN TCG) (NN GGG) (NN GG) (, ,) (JJ mBtkprom-Mut) (NN 3′-gcgg) (NN CCC) (NN CCC) (NN GAC) (NN ATT) (NN GTA) (NN CTG) (NN GGA) (NN CCT) (NN CT) (: ;) (JJ hBtkprom-Mut) (NN 5′-gcgg) (NN AGA) (NN GGT) (NN CCC) (NN AGT) (NN ACA) (NN ATG) (NN AAG) (NN GGC) (NN GG) (, ,) (JJ hBtkprom-Mut) (NN 3′-ggcg) (NN CCG) (NN CCC) (NN TTC) (NN ATT) (NN GTA) (NN CTG) (NN GGA) (NN CCT) (NN CT) (: ;) (NN Oct) (NN consensus) (NN 5′-gcgg) (NN ACC) (NN TGG) (NN GTA) (NN ATT) (NN TGC) (NN ATT) (NN TCT) (NN AAA) (IN AT) (, ,) (NN Oct) (NN consensus) (NN 3′-gcgg) (NN ATT) (NN TTA) (NN GAA) (NN ATG) (NN CAA) (NN ATT) (NN ACC) (NN CAG) (NN GT) (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (NN competition) (NNS experiments)))
      (, ,)
      (NP (DT the) (JJ unlabeled) (JJ annealed) (NNS oligonucleotides))
      (VP (VBD were)
        (VP (VBN used))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (VBN indicated) (NN amount))
        (PP (IN of)
          (NP (NNS oligonucleotides))))
      (VP (VBD was)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT the) (NN EMSA) (NN reaction) (NN mixture))))))
    (. .)))

(
  (S
    (S
      (PP (IN For)
        (NP (NN supershift) (NNS experiments)
          (NP
            (NP (DT an) (NN anti-Oct1-antibody))
            (PRN (-LRB- -LRB-)
              (NP (NN serum))
              (-RRB- -RRB-)))))
      (, ,)
      (NP (NN anti-Oct2-antibody))
      (-LRB- -LRB-)
      (NP (NN C-20))
      (: ;)
      (NP (NNP Santa) (NNP Cruz) (NN Biotechnology))
      (: ;)
      (NP (NN no)))
    (. .)))

(
  (S
    (NP
      (NP (NN sc-233))
      (-RRB- -RRB-)
      (CC or)
      (NP (NN anti-BOB.1/OBF.1-antibody)))))

(
  (S
    (S
      (PRN (-LRB- -LRB-)
        (NP (NN serum))
        (-RRB- -RRB-))
      (VP (VBD were)
        (VP (VBN used))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Modified) (NN EMSA) (NNS conditions))
        (PP (IN for)
          (NP
            (NP (DT the) (NN detection))
            (PP (IN of)
              (NP (JJ specific) (NN Oct/BOB.1/OBF.1) (NNS complexes))))))
      (VP (VBD were)
        (ADJP (RB previously) (VBN described) (-LRB- -LRB-)
          (NP (CD 55))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT these) (NNS experiments)))
    (NP
      (NP (CD 2) (JJ µg) (NNS HeLa-extracts))
      (CC and)
      (NP
        (NP
          (NP (CD 2.5) (JJ µl)
            (ADJP
              (ADVP (FW in) (FW vitro))
              (VBN translated))
            (NN BOB.1/OBF.1) (NN protein))
          (CC or)
          (NP
            (NP (DT the) (JJ same) (NN amount))
            (PP (IN of)
              (NP (JJ unprogrammed) (NNS TNT-lysates)))))
        (PRN (-LRB- -LRB-)
          (NP (NN Promega))
          (-RRB- -RRB-))))
    (VP (VBD were)
      (VP (VBN added)
        (SBAR
          (WHADVP (WRB where))
          (S
            (VP (VBN indicated))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The)
          (NP
            (NP (NN chromatin) (NN immunoprecipitation))
            (PRN (-LRB- -LRB-)
              (NP (NN ChIP))
              (-RRB- -RRB-)))
          (NN Assay) (NN kit))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNP Biomol) (NNP GmbH) (, ,) (NNP Hamburg) (, ,) (NNP Germany))
            (, ,)
            (NP (NNP #) (CD 17-295)))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (VP (VBN used)
          (PP (VBG according)
            (PP (TO to)
              (NP
                (NP (DT the) (NNS manufacturers) (NNS instructions))
                (PP (IN with)
                  (NP
                    (NP (JJ minor) (NNS modifications))
                    (VP (VBN described)
                      (ADVP (RB elsewhere))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 56))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS samples))
      (VP (VBD were)
        (VP (VBN amplified)
          (S
            (VP (VBG using)
              (NP
                (NP (NN Taq) (NN DNA) (NN polymerase))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Amersham) (NNP Pharmacia) (NNP Biotech))
                  (-RRB- -RRB-)))
              (S
                (VP (VBG using)
                  (NP (DT the) (VBG following) (NNS primers)))))))))
    (: :)
    (FRAG
      (NP (NN mBtkprom-ChIP) (NN 5′-GGT) (NN TAT) (NN GAC) (NN CTG) (NN TTG) (NN TTT) (NN GTT) (NN CAG) (NN C))
      (, ,)
      (NP
        (NP (NN mBtkprom-ChIP) (NN 3′-CAC) (NN CCT) (NN TTC) (NN GCA) (NN GCC))
        (VP (VB ACT)
          (NP
            (NP (NNP C.))
            (S
              (NP
                (NP (DT The) (NNS primers))
                (PP (IN for)
                  (NP
                    (NP (DT the) (NNS analyses))
                    (PP (IN of)
                      (NP (DT the) (NN H2B)
                        (CC or)
                        (NN Pax5) (NNS promoters))))))
              (VP (VBP are)
                (VP (VBN described)
                  (PP (IN in)
                    (NP (NN Ref))))))
            (. .) (-LRB- -LRB-) (CD 56) (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (NP (NNS RESULTS))))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN search))
          (PP (IN for)
            (NP (CD BOB.1/OBF.1) (NN target) (NNS genes)))))
      (NP (PRP we))
      (VP (VBD analyzed)
        (NP
          (NP (DT the) (NN promoter) (NNS regions))
          (PP (IN of)
            (NP
              (NP (NNS genes))
              (VP (VBN implicated)
                (PP (IN in)
                  (NP
                    (NP (NN B) (NN cell) (NN development))
                    (CC and)
                    (NP (NN function))))))))
        (PP (IN for)
          (NP
            (NP (DT the) (NN presence))
            (PP (IN of)
              (NP (DT the) (NN octamer) (NN motif)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Analyses))
        (PP (IN of)
          (NP (DT the)
            (ADJP
              (ADJP (JJ human))
              (CC and)
              (ADJP (JJ murine)))
            (NN Btk) (NNS promoters))))
      (VP (VBD revealed)
        (NP
          (NP (DT a) (VBN conserved) (JJ non-perfect) (NN octamer) (NN motif))
          (PP (IN within)
            (NP
              (NP (DT the) (JJ first) (CD 200) (NN bp))
              (ADVP (RB upstream)
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN start) (NN site))
                    (PP (IN of)
                      (NP
                        (NP (NN transcription))
                        (PRN (-LRB- -LRB-)
                          (NP (NN Figure) (CD 1))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT Both) (NN octamer) (NNS motifs))
      (VP (VBP differ)
        (PP (IN from)
          (NP
            (NP (DT the) (NN consensus) (NN sequence))
            (NN ATGCAAAT)))
        (PP (IN at)
          (NP (DT the) (JJ second) (NN position)))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (JJ human) (NN Btk) (NN promoter) (NN motif))
        (VP (VBZ bears)
          (NP (DT a) (JJ T→A) (NN transversion))))
      (, ,) (IN whereas)
      (S
        (NP (DT the) (JJ murine) (NN variant))
        (VP (VBZ shows)
          (NP (DT a) (JJ T→G) (NN transversion)))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP (PRP it))
          (VP (VBD was)
            (VP (VBN shown)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (DT a) (NN mutation))
                    (PP (IN in)
                      (NP
                        (NP (DT this) (NN position))
                        (PP (IN of)
                          (NP (DT the) (NN octamer) (NN motif))))))
                  (VP (VBZ interferes)
                    (PP (IN with)
                      (NP
                        (NP (NN Oct) (NN binding))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 9))
                          (-RRB- -RRB-)))))))))))
      (NP (PRP we))
      (VP (VBD wondered)
        (SBAR (IN whether)
          (S
            (NP (DT these) (NNS sites))
            (VP (MD might)
              (ADVP (RB nevertheless))
              (VP (VB play)
                (NP
                  (NP (DT a) (NN role))
                  (PP (IN for)
                    (NP (NN Btk) (NN promoter) (NN activity))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Initially))
      (, ,)
      (NP
        (NP (JJ nuclear) (NNS extracts))
        (PP (IN from)
          (NP (NN BJAB) (NNS cells))))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP (VBN labeled) (NNS probes))
              (VP (VBG bearing)
                (NP
                  (NP (CC either)
                    (NP (DT the) (NN consensus) (NN octamer) (NN motif))
                    (CC or)
                    (NP (DT the) (JJ putative) (NN octamer) (NN binding) (NNS sites)))
                  (VP (VBN identified)
                    (PP (IN in)
                      (NP
                        (NP (DT the)
                          (ADJP
                            (ADJP (JJ murine))
                            (CC or)
                            (ADJP (JJ human)))
                          (NN Btk) (NNS promoters))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN Figure) (NN 2A))
                            (CC and)
                            (NP (NN B)))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP (NN complex) (NN formation))
          (VP (VBD was)
            (ADJP (RB much) (JJR weaker))
            (PP (IN in)
              (NP
                (NP (DT the) (NN case))
                (PP (IN of)
                  (NP (DT the) (NN Btk) (NN promoter) (NNS sites)))))
            (PP (VBN compared)
              (PP (IN with)
                (NP (DT the) (NN consensus) (NN octamer) (NN motif)))))))
      (, ,)
      (NP (JJ similar) (NNS complexes))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN detected)
            (PP (IN upon)
              (NP (JJ extended) (NN exposure)))))))
    (. .)))

(
  (S
    (S
      (SBAR
        (WHADVP (WRB When))
        (S
          (NP
            (NP (DT the) (NN octamer) (NNS motifs))
            (PP (IN in)
              (NP (DT the)
                (ADJP
                  (ADJP (JJ murine))
                  (CC and)
                  (ADJP (JJ human)))
                (NN Btk) (NNS promoters))))
          (VP (VBD were)
            (ADVP (RB further))
            (VP
              (VP (VBN mutated))
              (CC and)
              (VP
                (ADVP (RB then))
                (VBN used)
                (PP (IN as)
                  (NP (NNS probes))))))))
      (, ,)
      (NP (DT no) (JJ specific) (NN binding))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN detected)
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (NN 2C))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NN complex) (NN formation))
      (VP (MD could)
        (VP (VB be)
          (ADVP (RB efficiently))
          (VP (VBN inhibited)
            (PP (IN by)
              (NP
                (NP (NN competition))
                (PP (IN with)
                  (NP
                    (NP (JJ unlabeled) (NNS oligonucleotides))
                    (VP (VBG bearing)
                      (NP (DT the) (JJ wild-type)
                        (ADJP
                          (ADJP (JJ murine))
                          (CC or)
                          (ADJP (JJ human)))
                        (NN Btk) (NN promoter) (NN octamer) (NNS motifs)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (VBN mutated) (NN octamer) (NNS motifs))
      (VP (VBD failed)
        (S
          (VP (TO to)
            (VP (VB compete)
              (PP (IN for)
                (NP
                  (NP
                    (NP
                      (NP (NN Oct1))
                      (CC and)
                      (NP (NN Oct2)))
                    (NN binding))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN Figure) (NN 2A))
                      (CC and)
                      (NP (NN B)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Competition))
      (VP (VBD was)
        (ADJP (RB much) (RBR more) (JJ efficient))
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP (DT a) (NN consensus) (NN octamer) (NN motif))
            (VP (VBD was)
              (VP (VBN used)
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NN Figure) (NN 2A))
                    (CC and)
                    (NP (NN B)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN supershift) (NNS experiments)))
      (NP (PRP we))
      (VP (MD could)
        (VP (VB demonstrate)
          (SBAR (IN that)
            (S
              (NP (DT the) (VBN shifted) (NNS complexes))
              (VP (VBP contain)
                (NP
                  (NP
                    (NP
                      (NP (NN Oct1))
                      (CC and)
                      (NP (NN Oct2)))
                    (NNS proteins))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Figure) (NNS 2D))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Oct2-specific) (NNS antibodies))
      (VP (VBD revealed)
        (NP
          (NP (JJ several) (VBN supershifted) (NNS complexes))
          (ADJP (JJ consistent)
            (PP (IN with)
              (NP
                (NP (DT the) (NN existence))
                (PP (IN of)
                  (NP
                    (NP (JJ several) (NN Oct2) (NNS isoforms))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 57))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (ADVP (RB Together))
    (NP (DT these) (NNS findings))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (VBN identified) (NN octamer) (NNS motifs))
            (PP (IN within)
              (NP (DT the)
                (ADJP
                  (ADJP (JJ murine))
                  (CC and)
                  (ADJP (JJ human)))
                (NN Btk) (NNS promoters))))
          (VP (VBP serve)
            (PP (IN as)
              (NP
                (NP (VBG binding) (NNS sites))
                (PP (IN for)
                  (NP
                    (NP (NN Oct1))
                    (CC and)
                    (NP (NN Oct2))))))
            (, ,)
            (PP (IN although)
              (S
                (VP (VBG showing)
                  (NP
                    (NP (VBN reduced) (NNS affinities))
                    (PP (IN for)
                      (NP
                        (NP (NN Oct1))
                        (CC and)
                        (NP (NN Oct2)))))
                  (PP (VBN compared)
                    (PP (IN with)
                      (NP (DT a) (NN consensus) (NN site)))))))))))
    (. .)))

(
  (S
    (ADVP (RB Next))
    (NP (PRP we))
    (VP (VBD asked) (, ,)
      (SBAR (IN whether)
        (S
          (NP (NN BOB.1/OBF.1))
          (VP (VBZ is)
            (ADJP (JJ able)
              (S
                (VP (TO to)
                  (VP (VB form)
                    (NP
                      (NP (JJ ternary) (NNS complexes))
                      (PP
                        (ADVP (RB together))
                        (IN with)
                        (NP
                          (NP (NN Oct1))
                          (CC and)
                          (NP (NN Oct2))))
                      (PP (IN on)
                        (NP (DT the)
                          (ADJP
                            (ADJP (JJ murine))
                            (CC and)
                            (ADJP (JJ human)))
                          (NN Btk) (NNS promoters))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (RB extremely) (JJ difficult)
          (S
            (VP (TO to)
              (VP (VB obtain)
                (NP (JJ ternary) (NNS complexes))
                (PP
                  (ADVP (RB even))
                  (IN on)
                  (NP (NN consensus) (NN octamer) (NNS motives)))
                (PP (IN by)
                  (NP
                    (NP (NN EMSA))
                    (PP (IN with)
                      (NP
                        (NP (JJ endogenous) (NNS proteins))
                        (PP (IN in)
                          (NP
                            (NP (NN B) (NN cell) (NNS extracts))
                            (PRN (-LRB- -LRB-)
                              (NP (NN 55,58))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP (PRP we))
      (VP (VBD used)
        (NP (DT an)
          (ADJP (FW in) (FW vitro))
          (NN complementation) (NN system))))
    (. .)))

(
  (S
    (S
      (NP (NN HeLa) (JJ nuclear) (NNS extracts))
      (VP (VBD were)
        (VP
          (VP (VBN complemented)
            (PP (IN with)
              (NP
                (ADJP
                  (ADVP (FW in) (FW vitro))
                  (VBN translated))
                (NN BOB.1/OBF.1))))
          (CC and)
          (VP (VBN incubated)
            (PP (IN with)
              (NP (CC either)
                (NP (DT the) (VBN labeled)
                  (NP (DT the) (NN consensus) (NN octamer) (NN motif)))
                (CC or)
                (NP
                  (NP (DT the) (NNS motifs))
                  (VP (VBN found)
                    (PP (IN in)
                      (NP
                        (NP (DT the)
                          (ADJP
                            (ADJP (JJ human))
                            (CC or)
                            (ADJP (JJ murine)))
                          (NN Btk) (NNS promoters))
                        (PRN (-LRB- -LRB-)
                          (NP (NN Figure) (CD 3))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Indeed))
      (, ,)
      (NP (JJ ternary) (NN complex) (NN formation))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN detected)
            (PP (IN at)
              (NP (DT these) (JJ non-conserved) (NN octamer) (NNS sequences)))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN Figure) (NN 3B))
                (CC and)
                (NP (NN C)))
              (, ,)
              (NP (NNP lane) (CD 3))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (NN Supershift) (NNS experiments))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (DT these) (NNS complexes))
            (VP (VBD were)
              (VP (VBN composed)
                (PP (IN of)
                  (NP
                    (NP
                      (NP (NN Oct1))
                      (CC and)
                      (NP (NN BOB.1/OBF.1)))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NN Figure) (CD 3))
                        (, ,)
                        (NP (NNS lanes)
                          (QP (CD 4)
                            (CC and)
                            (CD 5))))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (NP (NN BOB.1/OBF.1-specific))))

(
  (S
    (S
      (NP (NNS antibodies))
      (VP (VBD prevented)
        (NP (JJ ternary) (NN complex) (NN formation))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (DT an) (NN Oct1))
        (NN binding))
      (VP (VBD was)
        (ADVP (RB still))
        (ADJP (JJ possible))
        (PP (IN under)
          (NP
            (NP (DT these) (NNS conditions))
            (VP (VBG using)
              (NP (DT the) (NN consensus) (NN octamer) (NN site))
              (PP (IN as)
                (NP
                  (NP (JJ labeled) (NN probe))
                  (PRN (-LRB- -LRB-)
                    (VP (VB compare)
                      (NP (NNS lanes)
                        (QP (CD 2) (, ,) (CD 4)
                          (CC and)
                          (CD 8)))
                      (PP (IN in)
                        (NP (NN Figure) (NN 3A))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (ADJP (RB only) (RB very) (JJ weak))
      (NN Oct1) (NN binding))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN detected)
          (PP (IN with)
            (NP
              (NP (DT the) (JJ non-consensus) (NN Btk-octamer) (NNS motifs))
              (PRN (-LRB- -LRB-)
                (NP (NNS lanes)
                  (NP
                    (NP (CD 2))
                    (, ,)
                    (NP (CD 4))
                    (CC and)
                    (NP
                      (NP (CD 8))
                      (PP (IN in)
                        (NP (NNS Figures)
                          (NP
                            (NP (NN 3B))
                            (CC and)
                            (NP (NN C))))))))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Moreover))
      (, ,)
      (NP
        (NP (DT the) (NN addition))
        (PP (IN of)
          (NP (NN anti-Oct1) (NNS antibodies))))
      (VP (VBZ leads)
        (PP (TO to)
          (NP (DT a) (JJ clear) (NN Oct1) (NN supershift)))
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP (DT the) (NN consensus) (NN octamer) (NN site))
            (VP (VBD was)
              (VP (VBN used)
                (PP (IN as)
                  (NP (NN probe)))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (NN 3A))
                  (, ,)
                  (NP (NNP lane) (CD 5))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (DT no) (JJ clear) (NN Oct1) (NN supershift))
    (VP (MD could)
      (VP (VB be)
        (VP (VBN detected)
          (PP (IN with)
            (NP
              (NP (DT the) (NN Btk) (NN octamer) (NNS sites))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNS Figures)
                    (NP
                      (NP (NN 3B))
                      (CC and)
                      (NP (NN C))))
                  (, ,)
                  (NP (NNP lane) (CD 5)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (DT the) (JJ ternary) (NN complex) (NN formation))
      (VP (VBD was)
        (VP (VBN prevented) (, ,)
          (S
            (VP (VBG indicating)
              (SBAR (IN that)
                (S
                  (NP (DT this) (NN complex))
                  (VP (VBZ is)
                    (VP (VBN composed)
                      (PP (IN of)
                        (NP
                          (NP (NN BOB.1/OBF.1))
                          (CC and)
                          (NP (NN Oct1)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN addition))
        (PP (IN of)
          (NP (DT an) (JJ anti-Oct2) (NN antibody))))
      (VP (VBD did) (RB not)
        (VP (VB interfere)
          (PP (IN with)
            (NP (NN complex) (NN formation)))
          (PRN (-LRB- -LRB-)
            (NP (NN Figure) (CD 3))
            (, ,)
            (NP (NNP lane) (CD 6))
            (-RRB- -RRB-)))
        (, ,)
        (SBAR (IN since)
          (S
            (NP (NN HeLa) (NNS cells))
            (VP (VBP do) (RB not)
              (VP (VB express)
                (NP (NN Oct2))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS data))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (PP (IN in)
              (NP
                (NP (NN case))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ non-consensus) (NN octamer) (NNS sites))
                    (CD BOB.1/OBF.1)))))
            (VP (VBZ supports)
              (NP
                (NP (DT the) (NN binding))
                (PP (IN of)
                  (NP (NN Oct1)))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB investigate)
            (SBAR (IN whether)
              (S
                (NP (NN BOB.1/OBF.1))
                (VP (VBZ binds)
                  (PP (TO to)
                    (NP (DT the) (NN Btk) (NN promoter)))
                  (ADVP (FW in) (FW vivo))))))))
      (, ,)
      (NP (NN ChIP) (NNS experiments))
      (VP (VBD were)
        (VP (VBN performed)
          (S
            (VP (VBG using)
              (NP
                (NP (JJ primary) (NN B) (NNS cells))
                (VP (VBN isolated)
                  (PP (IN from)
                    (NP
                      (NP (NNS spleens))
                      (PP (IN of)
                        (NP (JJ wild-type) (NNS mice))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Oct1))
        (, ,)
        (NP (NN Oct2))
        (CC and)
        (NP (NN BOB.1/OBF.1)))
      (VP (VBP are)
        (NP
          (NP (DT all))
          (VP (VBD bound)
            (PP (TO to)
              (NP
                (NP (DT the) (JJ murine) (NN Btk) (NN promoter))
                (PP (IN in)
                  (NP (NN B) (NNS cells)))))
            (ADVP (FW in) (FW vivo))
            (PP (IN albeit)
              (PP (IN with)
                (NP
                  (NP (VBN reduced) (NN affinity))
                  (PP (IN in)
                    (NP
                      (NP (NN comparison))
                      (PP (TO to)
                        (NP (DT the)
                          (NP
                            (NP (NN H2B) (NN promoter))
                            (PRN (-LRB- -LRB-)
                              (NP (NN Figure) (CD 4))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB control)
            (PP (IN for)
              (NP
                (NP (DT the) (NN specificity))
                (PP (IN of)
                  (NP (DT the) (NN ChIP) (NNS experiments))))))))
      (, ,)
      (NP
        (NP (NNS antibodies))
        (VP (VBG recognizing)
          (NP
            (NP (JJ unrelated) (NNS proteins))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN PLCγ1))
                (CC and)
                (NP (NN Lyn)))
              (-RRB- -RRB-)))))
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN for)
            (NP (NN precipitation))))))
    (. .)))

(
  (S
    (S
      (NP (NN No) (NNS signals))
      (VP (VBD were)
        (VP (VBN observed)
          (PP (IN in)
            (NP
              (NP (DT these) (NNS controls))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 4))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP (DT no) (NN binding))
        (PP (IN of)
          (NP
            (NP (DT any))
            (PP (IN of)
              (NP (DT these) (NNS proteins)))))
        (PP (TO to)
          (NP
            (NP (DT the) (JJ murine) (NN Pax5) (NN promoter))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBZ does) (RB not)
                  (VP (VB contain)
                    (NP (DT an) (NN octamer) (NN motif)))))))))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN observed)))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP (PRP we))
          (VP (VBD observed)
            (NP
              (NP (NN binding))
              (PP (IN of)
                (NP
                  (NP (NN BOB.1/OBF.1))
                  (PP
                    (ADVP (RB together))
                    (IN with)
                    (NP (NNP Oct)))))
              (PP (TO to)
                (NP (DT the) (NN Btk) (NN promoter)))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD asked)
        (SBAR (IN whether)
          (S
            (NP (DT this) (NN binding))
            (VP (VBZ results)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN activation))
                  (PP (IN of)
                    (NP (NN Btk) (NN promoter) (NN activity))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP (DT the) (JJ murine) (NN Btk) (NN promoter))
      (VP (VBD was)
        (VP
          (VP (VBN cloned)
            (PP (IN in)
              (NP
                (NP (NN front))
                (PP (IN of)
                  (NP (DT a) (NN luciferase) (NN reporter) (NN gene))))))
          (CC and)
          (VP (VBN transfected)
            (PP (IN into)
              (NP (NN NIH/3T3) (NNS cells)))
            (PP (IN along)
              (PP (IN with)
                (NP
                  (NP (NN Oct2))
                  (, ,)
                  (NP (NN BOB.1/OBF1))))
              (CC or)
              (PP (IN with)
                (NP
                  (NP (NNS combinations))
                  (PP (IN of)
                    (NP (DT these) (NN expression) (NNS vectors))))))))))
    (. .)))

(
  (S
    (S
      (ADJP (JJ Consistent)
        (PP (IN with)
          (NP (PRP$ our) (NN binding) (NNS studies)))))
    (, ,)
    (NP (PRP we))
    (VP (VBD observed)
      (SBAR (IN that)
        (S
          (NP
            (NP (NN BOB.1/OBF.1))
            (PP
              (ADVP (RB together))
              (IN with)
              (NP (NN Oct2))))
          (VP (VBD was)
            (ADJP (JJ able)
              (S
                (VP (TO to)
                  (VP (VB activate)
                    (NP (DT the) (JJ murine) (NN Btk) (NN promoter))
                    (ADVP (RB ∼150-fold))
                    (PP (IN in)
                      (NP
                        (NP (DT a) (JJ dose-dependent) (NN manner))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (NP (NN Figure) (NN 5A))
                            (, ,)
                            (NP (NN B))
                            (CC and)
                            (NP
                              (NP (NNS data))
                              (VP (RB not) (VBN shown))))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (ADVP (RB Notably))
    (, ,)
    (NP
      (NP (NN Oct2))
      (PP
        (ADVP (RB together))
        (IN with)
        (NP (NN BOB.1/OBF.1))))
    (VP (VBD was)
      (NP
        (NP (DT a) (JJ potent) (NN inducer))
        (PP (IN of)
          (NP (NN Btk) (NN promoter) (NN activity))))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP (NN Oct1))
          (VP (VBD had)
            (NP (DT no) (NN effect))
            (PP (IN at)
              (NP (NN all)))
            (PRN (-LRB- -LRB-)
              (S
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Since)
        (S
          (NP (DT the)
            (NP
              (NP
                (NP (NN transcription) (NN factor) (NN PU.1))
                (VP (VBD was)
                  (VP (VBN shown)
                    (S
                      (VP (TO to)
                        (VP (VB be)
                          (ADJP (JJ important)
                            (PP (IN for)
                              (NP (DT the) (NN Btk) (NN promoter) (NN activity))))))))))
              (CC and)
              (NP (DT the) (NN PU.1)))
            (NNS sites))
          (VP (VBP are)
            (VP (VBN conserved)
              (PP (IN between)
                (NP
                  (NP (DT the)
                    (ADJP
                      (ADJP (JJ human))
                      (CC and)
                      (ADJP (JJ murine)))
                    (NN Btk) (NNS promoters))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Figure) (CD 1))
                    (-RRB- -RRB-))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD wondered)
        (SBAR (IN whether)
          (S
            (NP
              (NP (NN Oct2))
              (CC and)
              (NP (NN BOB.1/OBF.1)))
            (VP (MD can)
              (VP (VB enhance)
                (NP
                  (NP (JJ PU.1-mediated) (NN transactivation))
                  (PP (IN of)
                    (NP (DT the) (NN Btk) (NN promoter))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Transfection) (NNS experiments))
        (VP (VBG using)
          (NP (NN NIH/3T3) (NNS cells))))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN BOB.1/OBF.1))
              (PP
                (ADVP (RB together))
                (IN with)
                (NP (NN PU.1))))
            (ADVP (RB only) (RB marginally))
            (VP (VBD enhanced)
              (NP (JJ PU.1-mediated) (NN Btk) (NN promoter) (NN activity)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP
        (NP (NN co-transfection))
        (PP (IN of)
          (NP (NN Oct2)))
        (PP
          (ADVP (RB together))
          (IN with)
          (NP (NN PU.1))))
      (VP (VBD stimulated)
        (NP (JJ PU.1-mediated) (NN Btk) (NN promoter) (NN activity))
        (ADVP (RB significantly))
        (PRN (-LRB- -LRB-)
          (PP (IN from)
            (NP (CD 6-) (TO to) (RB 75-fold)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Moreover))
      (, ,)
      (NP
        (NP (NN co-transfection))
        (PP (IN of)
          (NP (NN PU.1)))
        (PP
          (ADVP (RB together))
          (IN with)
          (NP
            (NP (NN Oct2))
            (CC and)
            (NP (NN BOB.1/OBF.1)))))
      (VP (VBD led)
        (PP (TO to)
          (NP
            (NP
              (NP (DT an)
                (ADJP
                  (ADJP (RB even) (JJR stronger))
                  (CC and)
                  (ADJP (JJ synergistic)))
                (NN activation))
              (PRN (-LRB- -LRB-)
                (NP (NN 325-fold))
                (-RRB- -RRB-)))
            (PP (IN of)
              (NP (DT the)
                (NP
                  (NP (JJ murine) (NN Btk) (NN promoter))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Figure) (NN 5C))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN conclusion)))
      (NP (DT these) (NNS findings))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ transcriptional) (NN coactivator) (NN BOB.1/OBF.1))
            (VP (VBZ regulates)
              (NP
                (NP (DT the) (NN Btk) (NN promoter) (NN activity))
                (PP (IN in)
                  (NP (NN B) (NNS cells))))
              (ADVP (FW in) (FW vitro)
                (CONJP (RB as) (RB well) (IN as))
                (ADVP (FW in) (FW vivo)))
              (, ,)
              (PP (IN in)
                (NP
                  (NP (NN concert))
                  (PP (IN with)
                    (NP (NN Oct)
                      (CC and)
                      (NN PU.1) (NNS proteins))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (ADVP (RB further))
          (VP (VB analyze)
            (NP
              (NP (DT the)
                (ADJP (FW in) (FW vivo))
                (NN relevance))
              (PP (IN of)
                (NP (DT the) (NN Btk) (NN promoter) (NN octamer) (NN motif)))))))
      (NP (PRP we))
      (VP (VBD mutated)
        (NP
          (NP (DT the) (NN octamer) (NN sequence))
          (PP (IN from)
            (NP (NN AGGCAAAT))))
        (PP (TO to)
          (NP (NN AGtacAAT)))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN mutation))
      (VP (VBD prevented)
        (NP
          (NP (NN binding))
          (PP (IN of)
            (NP
              (NP (NN Oct) (NN transcription) (NNS factors))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (NN 2C))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (DT this) (VBN mutated) (NN construct))
        (VP (VBD was)
          (VP (VBN transfected)
            (PP (IN into)
              (NP
                (NP (DT the) (JJ murine) (NN B) (NN cell) (NN line))
                (NP (NN S194))))))))
    (NP (DT the) (NN activity))
    (VP (VBD was)
      (VP (VBN reduced)
        (PP (TO to)
          (NP (CD 60) (NN %)))
        (PP (VBN compared)
          (PP (IN with)
            (NP (DT the) (JJ wild-type) (NN Btk) (NN promoter) (-LRB- -LRB-) (NN Figure) (NN 6A) (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ demonstrates)
        (SBAR (IN that)
          (S
            (NP (DT the) (NN octamer) (NN motif))
            (ADVP (RB significantly))
            (VP (VBZ contributes)
              (PP (TO to)
                (NP
                  (NP (JJ overall) (NN promoter) (NN activity))
                  (PP (IN in)
                    (NP (NN addition)))
                  (PP (TO to)
                    (NP (DT the)
                      (NP
                        (NP (NN PU.1))
                        (CC and)
                        (NP (NN Sp1/Sp3)))
                      (NN binding) (NNS sites))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (NN prediction))
        (VP (VBN based)
          (PP (IN on)
            (NP (DT this) (NN result)))))
      (VP (MD would)
        (VP (VB be)
          (SBAR (IN that)
            (S
              (NP (NN Btk) (NN expression))
              (VP (MD should)
                (VP (VB be)
                  (VP (VBN attenuated)
                    (PP (IN in)
                      (NP
                        (NP (NN B) (NNS cells))
                        (VP (VBG lacking)
                          (NP (NN BOB.1/OBF.1) (NN expression)))))))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (ADVP (RB therefore))
    (VP (VBD examined)
      (NP
        (NP
          (NP
            (NP (NN IL-7-dependent))
            (CC and)
            (NP (NN stroma)))
          (JJ cell-dependent) (JJ pre) (NN B) (NN cell) (NNS lines))
        (VP (VBN established)
          (PP (IN from)
            (NP
              (NP (DT the) (NN bone) (NN marrow))
              (PP (IN of)
                (NP
                  (NP (JJ wild) (NN type))
                  (CC and)
                  (NP (NN BOB.1/OBF.1−/−)))))))))))

(
  (S
    (S
      (NP
        (NP (NNS mice))
        (PP (IN for)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP (NN Btk))))))
      (PRN (-LRB- -LRB-)
        (NP (NN Figure) (CD 6B))
        (-RRB- -RRB-)))
    (. .)))

(
  (S
    (ADVP (RB Indeed))
    (, ,)
    (NP (NN Btk) (NN protein) (NN expression))
    (VP (VBZ is)
      (VP (VBN reduced)
        (PP (IN in)
          (NP (NN BOB.1/OBF.1−/−)))))))

(
  (S
    (S
      (NP (JJ pre) (NN B) (NNS cells)))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (NN requirement))
      (PP (IN of)
        (NP (NN BOB.1/OBF.1)))
      (PP (IN for)
        (NP
          (NP (NN Btk) (NN expression))
          (PP (IN in)
            (NP (NN pre-B) (NN cell) (NNS lines))))))
    (VP (VBD was)
      (ADVP (RB further))
      (VP (VBN analysed)
        (PP (IN in)
          (NP
            (NP (JJ IL-7-dependent) (NN cell) (NNS lines))
            (VP (VBG expressing)
              (NP (DT a) (JJ conditional) (NN BOB.1/OBF.1) (NN transgene))
              (PP (IN on)
                (NP (DT a) (NN BOB.1/OBF.1−/−))))))))))

(
  (S
    (S
      (NP (JJ mutant) (NN background)))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB achieve)
            (NP
              (NP (JJ conditional) (NN expression))
              (PP (IN of)
                (NP (NN BOB.1.OBF.1)))))))
      (NP (DT the) (JJ tet-off) (NN system))
      (VP (VBD was)
        (VP (VBN used)
          (PRN (-LRB- -LRB-)
            (NP (NN 27,56,59))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In) (DT the) (NN absence) (IN of)
          (NP
            (NP (NN Doxycyclin))
            (PRN (-LRB- -LRB-)
              (NP (NN Dox))
              (-RRB- -RRB-))))
        (NP (DT the) (JJ co-activator) (NN BOB.1/OBF.1))
        (VP (VBZ is)
          (VP (VBN expressed))))
      (, ,) (IN whereas)
      (S
        (PP (IN in) (DT the) (NN presence) (IN of)
          (NP (NN Dox)))
        (NP (PRP$ its) (NN expression))
        (VP (VBZ is)
          (VP (VBN repressed)))))
    (. .)))

(
  (S
    (S
      (NP (NN RNA))
      (VP (VBD was)
        (VP
          (VP (VBN prepared)
            (PP (IN from)
              (NP
                (ADJP (CC either)
                  (ADJP (JJ untreated))
                  (CC or)
                  (ADJP (NN Dox) (JJ treated)))
                (NN pre-B) (NNS cells))))
          (CC and)
          (VP (VBN analysed)
            (PP (IN in)
              (NP (NN northern) (NN blot) (NNS experiments)))))))
    (. .)))

(
  (S
    (S
      (SBAR
        (WHADVP (WRB When))
        (S
          (NP (NN BOB.1/OBF.1) (NN expression))
          (VP (VBD was)
            (NP
              (NP (NN shut-off))
              (PP (IN by)
                (NP (NN doxycyclin) (NN addition)))))))
      (, ,)
      (NP
        (NP (DT the) (NN expression))
        (PP (IN of)
          (NP (NN Btk))))
      (VP (VBD was)
        (VP (VBN reduced)
          (S
            (ADVP (RB further))
            (VP (VBG supporting)
              (NP
                (NP (DT the) (JJ clear) (NN dependence))
                (PP (IN of)
                  (NP
                    (NP (NN Btk) (NN expression))
                    (PP (IN in)
                      (NP (JJ pre-B) (NNS cells)))))
                (PP (IN on)
                  (NP
                    (NP (NN BOB.1/OBF.1))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (NN 6C))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (VP (TO To)
        (VP (VB investigate) (, ,)
          (SBAR (IN whether)
            (S
              (NP
                (NP (DT the) (NN down-regulation))
                (PP (IN of)
                  (NP (NN Btk) (NN expression)))
                (PP (IN in)
                  (NP
                    (NP (DT the) (NN absence))
                    (PP (IN of)
                      (NP (NN BOB.1/OBF.1))))))
              (VP (VBZ is)
                (ADVP (RB also))
                (VP (VBN seen)
                  (PP (IN in)
                    (NP (JJ mature) (NN B220+) (NNS cells))))))))))
    (, ,)
    (S
      (NP (DT these) (NNS cells))
      (VP (VBD were)
        (VP (VBN sorted)
          (PP (IN by)
            (NP (NN FACS)))
          (PP (IN from)
            (NP
              (NP (NNS spleens))
              (PP (IN of)
                (NP
                  (NP (JJ wild) (NN type))
                  (CC and)
                  (NP (NN BOB.1/OBF.1−/−)))))))))))

(
  (S
    (S
      (NP (NNS mice))
      (CC and)
      (VP (VBN analyzed)
        (PP (IN by)
          (NP (NN protein) (NN immunoblot)))))
    (. .)))

(
  (S
    (ADVP (RB Again))
    (, ,)
    (NP (NN Btk) (NN expression))
    (VP (VBD was)
      (ADVP (RB strongly))
      (VP (VBN reduced)
        (PP (IN in)
          (NP (NN B220+) (NN BOB.1/OBF.1−/−)))))))

(
  (S
    (S
      (VP (NNS cells)
        (PP (IN in)
          (NP
            (NP (NN comparison))
            (PP (IN with)
              (NP
                (NP (JJ wild-type) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (NNS 6D))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (PP (IN in)
      (NP
        (NP (NN northern) (NN blot) (NNS analyses))
        (PP (IN of)
          (NP
            (NP (NN RNA))
            (VP (VBN prepared)
              (PP (IN from)
                (NP
                  (NP (NNS splenocytes))
                  (PP (IN of)
                    (NP
                      (NP (JJ wild) (NN type))
                      (CC or)
                      (NP (NN BOB.1/OBF.1−/−)))))))))))))

(
  (S
    (NP
      (NP (NNS mice))
      (S
        (NP (DT a) (VBN reduced) (NN Btk–mRNA) (NN expression))
        (VP (VBD was)
          (VP (VBN detected)
            (SBAR
              (WHADVP (WRB when))
              (S
                (NP (NN BOB.1/OBF.1))
                (VP (VBZ is) (RB not)
                  (VP (VBN expressed)
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (NN 6E))
                      (-RRB- -RRB-)))))))))
      (. .))))

(
  (S
    (S
      (ADVP (RB Together))
      (, ,)
      (NP (DT these) (NNS experiments))
      (ADVP (RB clearly))
      (VP (VBP indicate)
        (NP
          (NP (DT the) (JJ physiological) (NN importance))
          (PP (IN of)
            (NP (NN BOB.1/OBF.1)))
          (PP (IN for)
            (NP
              (NP (DT the) (JJ B-cell-specific) (NN expression))
              (PP (IN of)
                (NP (NN Btk))))))))
    (. .)))

(
  (S
    (NP (NN DISCUSSION))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN regulation))
        (PP (IN of)
          (NP
            (ADJP (NN B) (NN cell) (JJ type-specific))
            (NN gene) (NN expression))))
      (VP (VBZ plays)
        (NP
          (NP (DT an) (JJ essential) (NN role))
          (PP (IN for)
            (NP
              (NP (NN B) (NN cell) (NN generation))
              (, ,)
              (NP (NN maturation))
              (, ,)
              (NP (NN development))
              (CC and)
              (NP (NN function)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ large) (NN number))
        (PP (IN of)
          (NP (NN transcription) (NNS factors))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB be)
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (DT the) (NN regulation))
                        (PP (IN of)
                          (NP (NN B) (NN cell) (NN fate)))))))))
            (PRN (-LRB- -LRB-)
              (NP (CD 60))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One))
        (PP (IN of)
          (NP (DT those) (NNS factors))))
      (VP (VBZ is)
        (NP
          (NP (DT the) (JJ transcriptional) (NN coactivator) (CD BOB.1/OBF.1))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBZ enhances)
                (NP
                  (NP (DT the) (JJ transcriptional) (NN activity))
                  (PP (IN of)
                    (NP (DT the)
                      (NP
                        (NP (NN Oct1))
                        (CC and)
                        (NP (NN Oct2)))
                      (NN transcription) (NNS factors))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB get)
            (NP
              (NP (JJR more) (NNS insights))
              (PP (IN into)
                (NP
                  (NP (DT the) (JJ physiological) (NN role))
                  (PP (IN of)
                    (NP (NN BOB.1/OBF.1)))))))))
      (NP
        (NP (DT the) (JJ transcriptional) (NN network))
        (VP (VBN controlled)
          (PP (IN by)
            (NP (NN BOB.1/OBF.1)))))
      (VP (VBZ needs)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN elucidated)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Here))
      (NP (PRP we))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP (NN BOB.1/OBF.1))
            (VP (VBZ regulates)
              (NP (NN Btk) (NN gene) (NN expression)))))))
    (. .)))

(
  (S
    (SBAR (IN Although)
      (S
        (NP (DT the) (NN Btk) (NN promoter))
        (VP (VBD had)
          (VP (VBN been)
            (VP (VBN analyzed)
              (ADVP (RB quite) (RB extensively))
              (PP (IN for)
                (NP
                  (NP (NN binding))
                  (PP (IN of)
                    (NP
                      (NP (NN transcription) (NNS factors))
                      (PRN (-LRB- -LRB-)
                        (NP (NN 44–49))
                        (-RRB- -RRB-)))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN presence))
      (PP (IN of)
        (NP
          (NP (DT a) (JJ functional) (NN octamer) (NN site))
          (PP (IN within)
            (NP
              (NP (DT the) (JJ first) (CD 200) (NN bp))
              (ADVP (RB upstream)
                (PP (IN of)
                  (NP
                    (NP (DT the) (NN start) (NN site))
                    (PP (IN of)
                      (NP (NN transcription)))))))))))
    (VP (VBD had) (RB not)
      (VP (VBN been)
        (VP (VBN reported))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP (NN footprint) (NNS experiments))
          (VP (VBD identified)
            (NP
              (NP (DT a) (JJ protected) (NN region))
              (PP (IN in)
                (NP (DT the) (JJ human) (NN Btk) (NN promoter) (NN region)))
              (VP (VBG extending)
                (PP (IN from)
                  (NP
                    (NP (CD −130) (TO to) (CD −152) (NN bp))
                    (PRN (-LRB- -LRB-)
                      (S
                        (S
                          (NP (DT the) (JJ human) (NN Btk) (NN promoter) (NN octamer) (NN motif))
                          (VP (VBZ is)
                            (ADJP (JJ located)
                              (PP (IN at)
                                (NP
                                  (QP (CD −145) (TO to) (CD −152))
                                  (NN bp))))))
                        (: ;)
                        (S
                          (VP (VB see)
                            (NP (NN Figure) (CD 1)))))
                      (-RRB- -RRB-)))))))))
      (, ,)
      (NP (DT this) (NN area))
      (VP (VBD was)
        (ADVP (RB only))
        (VP (VBN analyzed)
          (PP (IN for)
            (NP
              (NP (DT the) (NN binding))
              (PP (IN of)
                (NP (NN Sp1/3) (NNS factors)))
              (PP (TO to)
                (NP
                  (NP (DT the) (NN GC) (JJ rich) (NN box))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 48))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP (DT the) (NN DNA) (NN probe))
        (VP (VBN used)
          (PP (IN in)
            (NP (NN gel) (NN shift) (NNS experiments)))
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP (NN Sp1/3) (NN binding)))))))
      (VP (VBD did) (RB not)
        (VP (VBP encompass)
          (NP (DT the) (NN octamer) (NN motif)))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (JJ protein–DNA) (NNS complexes))
        (VP (VBG reflecting)
          (NP
            (NP (NN Oct) (NN binding))
            (PP (TO to)
              (NP (DT the) (NN Btk) (NN promoter))))))
      (VP (MD could) (RB not)
        (VP (VB be)
          (VP (VBN observed)
            (PP (IN in)
              (NP (DT these) (NNS experiments)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (PP (IN in)
        (NP
          (NP (NN search))
          (PP (IN for)
            (NP
              (NP (NNS factors))
              (VP (VBN involved)
                (PP (IN in)
                  (NP (JJ cell-type-specific) (NN Btk) (NN expression))))))))
      (, ,)
      (NP
        (NP (DT those) (NN protein) (NNS complexes))
        (VP (VBN observed)
          (PP (IN in)
            (NP (NN gel) (NN shift) (NNS experiments)))))
      (VP (VBD were)
        (VP (VBN excluded)
          (PP (IN from)
            (NP
              (NP (JJ detailed) (NNS analyses))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBD were)
                    (VP (VBN found)
                      (S
                        (VP (TO to)
                          (VP (VB bind)
                            (PP (TO to)
                              (NP (DT the) (NN Btk) (NN promoter)))
                            (PP
                              (ADVP (RB also))
                              (IN in)
                              (NP
                                (NP (NNS cells))
                                (VP (VBD were)
                                  (NP
                                    (NP (NN Btk))
                                    (VP (VBZ is) (RB not)
                                      (VP (VBN expressed)
                                        (PP (JJ such) (IN as)
                                          (NP
                                            (NP (NN T) (NNS cells))
                                            (CC and)
                                            (NP
                                              (NP (NNS fibroblasts))
                                              (PRN (-LRB- -LRB-)
                                                (NP (CD 46))
                                                (-RRB- -RRB-)))))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (S
        (NP (NN Oct) (NNS proteins))
        (VP (VBP are) (RB not)
          (ADVP (RB exclusively))
          (VP (VBN expressed)
            (PP (IN in)
              (NP (NN B) (NNS cells))))))
      (CC and)
      (S
        (NP (NN Oct1))
        (VP (VBZ is)
          (ADVP (RB also))
          (VP (VBN found)
            (PP (IN in)
              (NP
                (NP (NN T) (NNS cells))
                (CC and)
                (NP (NNS fibroblasts))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (MD could)
        (VP (VB show)
          (SBAR (IN that)
            (S
              (NP
                (NP (NN Oct1))
                (CONJP (RB as) (RB well))
                (NP (NN Oct2)))
              (VP (VBP are)
                (ADJP (JJ able)
                  (S
                    (VP (TO to)
                      (VP (VB bind)
                        (PP (TO to)
                          (NP (DT the) (NN murine)))
                        (ADVP (RB as) (RB well))
                        (PP (TO to)
                          (NP (DT the) (JJ human) (NN Btk) (NN promoter)))
                        (, ,)
                        (SBAR (IN albeit)
                          (S
                            (NP (DT this) (NN binding) (NN activity))
                            (VP (VBD was)
                              (ADJP
                                (ADJP (RB much) (JJR weaker))
                                (PP (IN than)
                                  (NP
                                    (NP (DT that))
                                    (VP (VBN observed)
                                      (S
                                        (VP (VBG using)
                                          (NP (DT a) (NN consensus) (NN octamer) (NN site)))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP (JJ ternary) (NNS complexes))
        (VP (VBN composed)
          (PP (IN of)
            (NP
              (NP (NN Oct1))
              (CC and)
              (NP (NN BOB.1/OBF.1))))))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN detected)
            (PP (IN on)
              (NP
                (NP (DT the)
                  (ADJP
                    (ADJP (JJ murine))
                    (CC and)
                    (ADJP (JJ human)))
                  (NN Btk) (NN Oct) (NNS sites))
                (PP (IN in)
                  (NP (DT a) (JJ reconstituted) (NN system)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (ADVP (RB clearly))
      (VP (VBZ demonstrates)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN Oct) (NNS proteins))
              (PP
                (ADVP (RB together))
                (IN with)
                (NP (NN BOB.1/OBF.1))))
            (VP (VBP are)
              (ADJP (JJ able)
                (S
                  (VP (TO to)
                    (VP (VB bind)
                      (PP (TO to)
                        (NP
                          (NP (DT the) (NN non-perfect) (NN Oct) (NNS motifs))
                          (VP (VBN found)
                            (PP (IN in)
                              (NP (DT the) (NN Btk) (NN promoter))))))
                      (ADVP (FW in) (FW vitro)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (SBAR (IN whereas)
        (S
          (PP (IN in)
            (NP
              (NP (DT the) (NN absence))
              (PP (IN of)
                (NP (NN BOB.1/OBF.1)))))
          (NP
            (NP (RB only) (DT a) (JJ weak) (NN binding))
            (PP (IN of)
              (NP (NN Oct) (NNS factors))))
          (VP (VBD was)
            (VP (VBN observed)))))
      (, ,)
      (NP (DT the) (JJ ternary) (NN complex) (NN formation))
      (VP (VBD was)
        (VP (VBN found)
          (S
            (ADJP (JJ similar)
              (PP (TO to)
                (NP
                  (NP (DT that))
                  (VP (VBN formed)
                    (PP (IN on)
                      (NP (DT the) (NN consensus) (NN octamer) (NN motif)))))))))))
    (. .)))

(
  (S
    (NP (JJ Similar) (NNS results))
    (VP (VBD were)
      (VP (VBN observed)
        (SBAR
          (WHADVP (WRB when))
          (S
            (NP (DT the)
              (NP
                (NP (NN Oct-dependent))
                (CC and)
                (NP (NN BOB.1/OBF.1-dependent))))))))))

(
  (S
    (S
      (NP (NN osteopontin) (NN promoter))
      (VP (VBD had)
        (VP (VBN been)
          (VP (VBN analyzed)
            (PRN (-LRB- -LRB-)
              (NP (NN 61,62))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN promoter))
      (VP (VBZ contains)
        (NP
          (NP
            (NP (DT a) (NN PORE))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (JJ Palindromic) (NN Oct) (NN factor) (NN Recognition) (NN Element))
                (: ;)
                (NP (NN ATTTG) (-LRB- -LRB-) (NN N5) (-RRB- -RRB-) (NN CAAAT)))
              (-RRB- -RRB-)))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ enables)
                (S
                  (NP (NN Oct) (NNS factors))
                  (VP (TO to)
                    (VP (VB assemble)
                      (NP
                        (NP
                          (ADJP (JJ homo-)))
                        (CC or)
                        (NP (NNS hetero-dimers)))
                      (PP (IN at)
                        (NP (DT this) (NN site)))
                      (ADVP (FW in) (FW vitro)))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ PORE-mediated) (NN Oct) (NN dimerization))
      (VP (VBD was)
        (VP (VBN suggested)
          (S
            (VP (TO to)
              (VP (VB be)
                (NP
                  (NP (DT an) (JJ essential) (NN prerequisite))
                  (PP (IN for)
                    (NP
                      (NP (NN binding))
                      (PP (IN of)
                        (NP (NN BOB.1/OBF.1)))
                      (PP (TO to)
                        (NP
                          (NP (PDT such) (DT an) (NN octamer) (NN site))
                          (PRN (-LRB- -LRB-)
                            (NP (CD 63))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS studies))
      (ADVP (RB also))
      (VP (VBD demonstrated)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN transversion) (NN T→G))
              (PP (IN at)
                (NP
                  (NP (DT the) (JJ second) (NN position))
                  (PP (IN of)
                    (NP (DT the) (NN consensus) (NN octamer) (NN site)))))
              (-LRB- -LRB-)
              (VP (VBN identified)
                (PP (IN in)
                  (NP (DT the) (JJ murine) (NN Btk) (NN promoter))))
              (-RRB- -RRB-))
            (VP (VBZ impairs)
              (NP (NN Oct) (NN binding)))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (NP (NN luciferase) (NN reporter) (NNS assays))
    (VP (VBD revealed)
      (SBAR (IN that)
        (S
          (NP (DT the) (NN T→G) (NN transversion))
          (VP (VBZ results)
            (PP (IN in)
              (NP
                (NP (VBN increased) (NN promoter) (NN activity))
                (PP (IN in)
                  (NP
                    (NP (NN comparison))
                    (PP (TO to)
                      (NP
                        (NP (DT the) (JJ wild-type) (NN PORE) (NN promoter))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 62))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN line))
          (PP (IN with)
            (NP (DT this) (NN observation)))))
      (NP (PRP it))
      (VP (VBD was)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP (NN BOB.1/OBF.1))))
              (VP (VBZ enables)
                (S
                  (NP (NN Oct) (NNS factors))
                  (VP (TO to)
                    (VP (VB bind)
                      (PP (TO to)
                        (NP
                          (NP (DT this) (JJ unfavorable) (JJ non-consensus) (NN octamer) (NNS motifs))
                          (PRN (-LRB- -LRB-)
                            (NP (CD 62))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP
            (NP (DT the) (NN octamer) (NNS motifs))
            (VP (VBN identified)
              (PP (IN in)
                (NP (NN Btk) (NN promoter)))))
          (VP (VBP do) (RB not)
            (VP (VB represent)
              (NP (JJ classical) (NN PORE) (NNS motifs))))))
      (, ,)
      (NP (PRP we))
      (VP (VBP show)
        (ADVP (RB here))
        (SBAR (IN that)
          (S
            (NP
              (NP (NN Oct) (NNS proteins))
              (CC and)
              (NP (CD BOB.1/OBF.1)))
            (VP (VBP bind)
              (PP (TO to)
                (NP (DT this) (NN site)))
              (ADVP (FW in) (FW vitro)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (NP
        (NP (DT the) (NN presence))
        (PP (IN of)
          (NP (NN BOB.1/OBF.1))))
      (VP (VBZ facilitates)
        (NP
          (NP (NN binding))
          (PP (IN of)
            (NP (NN Oct) (NNS proteins)))
          (PP (TO to)
            (NP
              (NP
                (ADVP (IN at) (JJS least))
                (DT a) (NN subset))
              (PP (IN of)
                (NP (JJ non-consensus) (NN octamer) (NNS motifs))))))))
    (. .)))

(
  (S
    (S
      (NP (NN ChiP) (NNS experiments))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP (JJ ternary) (NN complex) (NN formation))
            (ADVP (RB also))
            (VP (VBZ occurs)
              (ADVP (FW in) (FW vivo)))))))
    (. .)))

(
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (NN Oct)
        (CC and)
        (NN BOB.1/OBF.1) (NNS proteins))
      (VP (VB act)
        (PP (IN in)
          (NP
            (NP (NN synergy))
            (PP (IN with)
              (NP
                (NP
                  (NP (DT PU.1—a)
                    (ADJP (RB previously) (VBN identified))
                    (NN factor))
                  (ADJP (JJ important)
                    (PP (IN for)
                      (NP (NN Btk) (NN promoter) (NN regulation)))))
                (PRN (-LRB- -LRB-)
                  (NP (NN 46,48,49))
                  (-RRB- -RRB-))))))))
    (ADVP (RB —to))
    (VP (VBP induce)
      (NP (NN Btk) (NN promoter) (NN activity)))
    (. .)))

(
  (S
    (SBAR (IN Since)
      (S
        (NP
          (NP (DT the) (NN PU.1) (NN binding) (NN site))
          (VP (VBN identified)
            (PP (IN in)
              (NP (DT the) (JJ human) (NN Btk) (NN promoter)))))
        (VP (VBZ is)
          (VP
            (VP (VBN conserved))
            (CC and)
            (ADJP (JJ present)
              (PP (IN in)
                (NP (DT the)
                  (NP
                    (NP (JJ murine) (NN Btk) (NN promoter))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (CD 1))
                      (-RRB- -RRB-))))))))))
    (NP (PRP we))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN mechanism))
            (PP (IN of)
              (NP (NN Btk) (NN gene) (NN regulation)))
            (PP (IN by)
              (NP
                (NP (NN Oct/BOB.1/OBF.1))
                (CC and)
                (NP (NN PU.1)))))
          (VP (VBZ is)
            (VP (VBN conserved)
              (PP (IN between)
                (NP
                  (NP (NN mouse))
                  (CC and)
                  (NP (NNS humans)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN importance))
        (PP (IN of)
          (NP (NN PU.1)))
        (PP (IN for)
          (NP (NN Btk) (NN gene) (NN regulation))))
      (VP (VBZ is)
        (VP (VBN underlined)
          (PP (IN by)
            (NP (DT the) (NN fact)
              (SBAR (IN that)
                (S
                  (NP
                    (NP (DT the) (NN absence))
                    (PP (IN of)
                      (NP (NN PU.1))))
                  (VP (VBZ leads)
                    (PP (TO to)
                      (NP
                        (NP (DT a)
                          (QP (CD two-) (TO to) (JJ 3-fold))
                          (NN reduction))
                        (PP (IN of)
                          (NP (NN Btk) (NN expression)))
                        (-LRB- -LRB-) (CD 48) (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP
        (NP (DT the) (NN deficiency))
        (PP (IN of)
          (NP
            (NP
              (NP (NN Sp1))
              (SBAR
                (WHNP (WDT that))
                (S
                  (ADVP (RB also))
                  (VP (VBZ stimulates)
                    (NP (NN Btk) (NN promoter) (NN activity))))))
            (CONJP (RB together) (IN with))
            (NP (NN PU.1) (-LRB- -LRB-) (CD 49) (-RRB- -RRB-)))))
      (VP (VBD had)
        (NP
          (NP (DT no) (NN influence))
          (PP (IN on)
            (NP (NN Btk) (NN expression))))
        (PRN (-LRB- -LRB-)
          (NP (CD 49))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (ADVP (RB Here))
    (NP (PRP we))
    (VP (VBD showed)
      (SBAR (IN that)
        (S
          (NP (NN BOB.1/OBF.1-deficiency)))))))

(
  (S
    (NP
      (NP (NNS results))
      (PP
        (PP (IN in)
          (NP
            (NP (DT a) (JJ severe) (NN reduction))
            (PP (IN of)
              (NP (NN Btk) (NN expression)))
            (PP (IN in)
              (NP (JJ immature) (NN bone) (NN marrow) (VBN derived) (JJ pre-B) (NNS cells)))))
        (CONJP (RB as) (RB well) (IN as))
        (PP (IN in)
          (NP (JJ peripheral) (NN B220+) (NNS splenocytes))))
      (. .))))

(
  (S
    (S
      (NP (DT These) (NNS data))
      (VP (VBP indicate)
        (NP
          (NP (DT the) (JJ physiological) (NN importance))
          (PP (IN of)
            (NP
              (NP (NN Oct/BOB.1/OBF.1))
              (PP
                (ADVP (RB together))
                (IN with)
                (NP (NN PU.1)))))
          (PP (IN in)
            (NP
              (ADJP (NN B) (JJ cell-specific))
              (NN Btk) (NN gene) (NN regulation))))
        (PP (IN at)
          (NP
            (NP
              (ADJP
                (ADJP (JJ early))
                (CC and)
                (ADJP (JJ late)))
              (NNS stages))
            (PP (IN of)
              (NP (NN B) (NN cell) (NN development)))))))
    (. .)))

(
  (S
    (S
      (SBAR (IN If)
        (S
          (NP (NN Btk))
          (VP (VBZ is)
            (NP
              (NP (DT a) (JJ direct) (NN target))
              (PP (IN of)
                (NP (NN BOB.1/OBF.1)))))))
      (NP
        (NP (DT the) (NN phenotype))
        (PP (IN of)
          (NP
            (NP (NNS mice))
            (ADJP (JJ deficient)
              (PP (IN in)
                (NP (CC either)
                  (NP (NN BOB.1/OBF.1))
                  (CC or)
                  (NP (NN Btk))))))))
      (VP (MD should)
        (VP (VB be)
          (ADJP (JJ related)))))
    (. .)))

(
  (S
    (ADVP (RB Indeed))
    (, ,)
    (NP (DT both) (JJ knock-out) (NNS mice))
    (VP (VBP share)
      (NP (JJ similar) (NNS characteristics))
      (, ,)
      (PP (IN like)
        (NP
          (NP (NNS defects))
          (PP (IN in)
            (NP
              (NP (NN B) (NN cell) (NN development))
              (PP (IN in)
                (NP
                  (NP (NN bone) (NN marrow))
                  (CC and)
                  (NP (NN spleen))))))))
      (, ,)
      (S
        (VP (VBG resulting)
          (PP (IN in)
            (NP
              (NP (DT a)
                (ADJP (CD 2-) (TO to) (JJ 4-fold))
                (NN reduction))
              (PP (IN of)
                (NP
                  (NP (JJ peripheral) (NN B) (NN cell) (NN number))
                  (CC and)
                  (NP
                    (NP (NNS defects))
                    (PP (IN in)
                      (NP (NN B) (NN cell) (NN receptor) (NN signaling)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (DT both) (JJ knock-out) (NNS mice))
      (VP (VBP have)
        (ADVP (RB also))
        (NP (JJ unique) (NNS features))))
    (: :)
    (SBAR (IN whereas)
      (S
        (NP (DT the) (JJ marginal) (NN zone) (NN B) (NN cell) (NN compartment))
        (VP (VBZ is)
          (ADJP (RB almost) (JJ missing)
            (PP (IN in)
              (NP (NN BOB.1/OBF.1−/−)))))))))

(
  (S
    (S
      (NP (NNS mice))
      (LST (-LRB- -LRB-) (CD 27) (-RRB- -RRB-))
      (NP (DT this) (NN B) (NN cell) (NN subset))
      (VP (VBD was)
        (VP (VBN found)
          (ADVP (JJ normal))
          (PP (IN in)
            (NP (JJ Xid) (NNS mice))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP (DT the) (NN B-1) (NN population))
    (VP (VBZ is)
      (UCP
        (VP (VBN depleted)
          (PP (IN in)
            (NP
              (NP (JJ Xid) (NNS mice))
              (PRN (-LRB- -LRB-)
                (NP (NN 33,34,64))
                (-RRB- -RRB-)))))
        (CC and)
        (ADJP (JJ normal)
          (PP (IN in)
            (NP (NN BOB.1/OBF.1−/−))))))))

(
  (S
    (NP
      (NP (NNS mice))
      (. .))))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP (NNS mice))
        (ADJP (JJ mutant)
          (PP (IN for)
            (NP (DT both) (NNS proteins)))))
      (VP (VBP show)
        (NP
          (NP (DT a)
            (ADJP (RBR more) (JJ severe))
            (NN defect))
          (PP (IN than)
            (NP (DT each) (NN mouse) (PRP itself))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN phenotype))
      (VP (VBZ resembles)
        (NP
          (NP (DT that))
          (PP (IN of)
            (NP
              (NP (JJ severe) (NN agammaglobulinemia))
              (PP (IN in)
                (NP
                  (NP (JJ human) (NNS XLA))
                  (PRN (-LRB- -LRB-)
                    (NP (NN 31,39))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (NN Btk))
        (CC and)
        (NP (NN BOB.1/OBF.1)))
      (VP (VBP seem)
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN involved)
                (PP (IN in)
                  (NP
                    (ADJP
                      (ADJP (JJ overlapping))
                      (CONJP (RB as) (RB well) (IN as))
                      (ADJP (JJ distinct)))
                    (NN signaling) (NNS pathways)))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBN Taken)
          (ADVP (RB together))))
      (, ,)
      (NP
        (NP (DT the) (NNS analyses))
        (PP (IN of)
          (NP (DT the)
            (ADJP
              (ADJP (JJ murine))
              (CC and)
              (ADJP (JJ human)))
            (NN Btk) (NN promoter))))
      (VP (VBD revealed)
        (NP
          (NP (DT the) (NN presence))
          (PP (IN of)
            (NP (DT a) (JJ functional) (NN octamer) (NN motif))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (DT The) (NN transcription) (NNS factors))
          (NP (NN Oct1/2)))
        (CONJP (RB as) (RB well) (IN as))
        (NP (DT the) (NN coactivator) (NN BOB.1/OBF.1)))
      (VP (VBP bind)
        (PP (TO to)
          (NP (DT these) (NNS sites)))
        (ADVP
          (ADVP (FW in) (FW vitro))
          (CC and)
          (ADVP (FW in) (FW vivo)))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (JJ physiological) (NN relevance))
      (PP (IN of)
        (NP (DT the) (NN octamer))))
    (VP (VBD was)
      (VP (VBN shown)
        (PP (IN in)
          (NP (NN BOB.1/OBF.1−/−)))))))

(
  (S
    (S
      (NP (NN B) (NNS cells))
      (VP (VBD were)
        (S
          (NP
            (NP (DT the) (NN expression))
            (PP (IN of)
              (NP (NN Btk))))
          (VP (VBZ is)
            (ADVP (RB strongly))
            (VP (VBN reduced))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN finding)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP (NN BOB.1/OBF.1))))
            (VP (VBZ facilitates)
              (NP
                (NP (DT the) (NN binding))
                (PP (IN of)
                  (NP (NN Oct) (NNS factors)))
                (PP (TO to)
                  (NP
                    (NP (DT the) (JJ non-consensus) (NN octamer) (NN sequence))
                    (VP (VBN identified)
                      (PP (IN in)
                        (NP (DT the)
                          (ADJP
                            (ADJP (JJ human))
                            (CC and)
                            (ADJP (JJ murine)))
                          (NN Btk) (NNS promoters)))))))))))
      (VP (MD could)
        (VP (VB reflect)
          (NP
            (NP (DT a) (NN mechanism))
            (PP (IN of)
              (NP
                (NP (JJ fine-tuned) (NN regulation))
                (PP (IN of)
                  (NP (NN promoter) (NN activity))))))
          (PP (VBG depending)
            (PP (IN on)
              (NP
                (NP (NN Oct))
                (CC and)
                (NP (NN BOB.1/OBF.1))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (NP
      (NP (NN Figure) (CD 1))
      (: :)
      (NP
        (NP (JJ Comparative) (NN analysis))
        (PP (IN of)
          (NP (DT the)
            (ADJP
              (ADJP (JJ human))
              (CC and)
              (ADJP (JJ murine)))
            (NN Btk) (NNS promoters))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN Nucleotide) (NNS sequences))
        (PP (IN of)
          (NP (DT the)
            (ADJP
              (ADJP (JJ human)
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD +33) (TO to) (CD −232))
                    (NN bp))
                  (-RRB- -RRB-)))
              (CC and)
              (ADJP (JJ murine)
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD +33) (TO to) (CD −243))
                    (NN bp))
                  (-RRB- -RRB-))))
            (NN Btk) (NNS promoters))))
      (VP (VBP are)
        (VP (VBN presented))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS positions))
        (PP (IN of)
          (NP
            (NP (DT the) (NN octamer) (NN motif))
            (, ,)
            (NP
              (NP (DT the) (NN GT-))
              (, ,)
              (ADJP (JJ GC-)))
            (CC and)
            (NP (NN Pu-boxes))
            (CONJP (RB as) (RB well) (IN as))
            (NP
              (NP
                (NP (DT the) (NN initiator) (NN site))
                (CC and)
                (NP
                  (NP (DT the) (NN start) (NN site))
                  (PP (IN of)
                    (NP (NN transcription)))))
              (PRN (-LRB- -LRB-)
                (NP (NN +1))
                (-RRB- -RRB-))))))
      (VP (VBP are)
        (VP (VBN indicated))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Figure) (CD 2))
        (: :)
        (NP (NN Octamer) (NNS factors)
          (NP
            (NP (NN Oct1))
            (CC and)
            (NP (NN Oct2)))))
      (VP (VBP bind)
        (PP (TO to)
          (NP
            (NP (DT the) (JJ non-consensus) (NN octamer) (NN site))
            (PP (IN of)
              (NP (DT the)
                (ADJP
                  (ADJP (JJ murine))
                  (CC and)
                  (ADJP (JJ human)))
                (NN Btk) (NNS promoters)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP
            (NP (-LRB- -LRB-)
              (NP
                (NP (NN A))
                (CC and)
                (NP (NN B)))
              (-RRB- -RRB-) (NNS EMSA))
            (PP (IN with)
              (NP
                (NP (JJ nuclear) (NNS extracts))
                (PP (IN from)
                  (NP (DT the) (NN B) (NN cell) (NN line) (NN BJAB))))))
          (CC and)
          (NP (VBN labeled) (NNS probes)))
        (VP (VBG presenting)
          (NP (CC either)
            (NP
              (NP (DT a) (NN consensus) (NN octamer) (NN site))
              (PRN (-LRB- -LRB-)
                (NP (NN Oct) (NNS cons))
                (-RRB- -RRB-)))
            (CC or)
            (NP (DT the) (JJ non-conserved) (NN octamer) (NN site)))))
      (VP (VBN identified)
        (PP (IN in)
          (NP (DT the)
            (ADJP
              (ADJP (JJ human))
              (CC and)
              (ADJP (JJ murine)))
            (NN Btk) (NNS promoters)))
        (PRN (-LRB- -LRB-)
          (NP (NNP murBtkprom) (, ,) (NNP humBtkprom))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (NP
      (NP (NN Competitor) (NN binding) (NNS sites))
      (PP
        (PP (IN with)
          (NP
            (NP
              (NP (DT the) (JJ wild-type))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN murBtkprom))
                  (, ,)
                  (NP (NN humBtkprom)))
                (-RRB- -RRB-)))
            (CC or)
            (NP
              (NP (VBN mutated) (NN octamer) (NN mortif))
              (PP (IN from)
                (NP (DT the) (NN Btk) (NN promoter))))
            (NP
              (NP (JJ -LSB-mBtkprom) (NN Mut))
              (PRN (, ,)
                (NP
                  (NP (NN humBtkprom) (NN Mut))
                  (: ;)
                  (S
                    (NP
                      (NP (DT the) (NN octamer) (NNS motifs))
                      (NP (DT A) (-LRB- -LRB-) (NN A/G) (-RRB- -RRB-) (NN GCAAAT)))
                    (VP (VBD were)
                      (VP (VBN mutated)
                        (PP (TO to)
                          (NP (NN AgtacAAT)))))))
                (-RRB- -RSB-)))))
        (CC or)
        (PP (IN with)
          (NP (DT the) (NN consensus) (NN octamer)
            (PRN (-LRB- -LRB-)
              (NP (NN Oct) (NNS cons))
              (-RRB- -RRB-))
            (NN site)))))
    (VP (VBD were)
      (VP (VBN added)
        (PP (IN in)
          (NP
            (NP (JJ different) (JJ molar) (NN excess))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NN 10×))
                (, ,)
                (NP (NN 30×))
                (, ,)
                (NP (NN 100×)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))
      (NP (DT The) (VBN mutated) (NNS sites))
      (VP (VBD were)
        (ADVP (RB also))
        (ADJP (JJ unable)
          (S
            (VP (TO to)
              (VP (VB bind)
                (NP
                  (NP
                    (NP (NN Oct1))
                    (CC or)
                    (NP (NN Oct2)))
                  (NNS proteins))))))
        (SBAR
          (WHADVP (WRB when))
          (S
            (VP (VBN tested)
              (PP (IN as)
                (NP (VBN labeled) (NNS probes))))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-))
      (NP (NN EMSA))
      (VP (NN supershift)
        (PP (IN with)
          (NP
            (NP (DT the) (VBN indicated) (NNS probes))
            (CC and)
            (NP
              (NP (NNS antibodies))
              (ADJP (JJ specific)
                (PP (IN for)
                  (NP
                    (NP (NN Oct1))
                    (CC and)
                    (NP (NN Oct2))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN EMSA) (NNS experiments))
        (VP (VBG using)
          (NP
            (NP (DT the) (JJ non-conserved) (NN octamer) (NN site))
            (VP (VBN identified)
              (PP (IN in)
                (NP
                  (NP (DT the)
                    (ADJP
                      (ADJP (JJ human))
                      (CC and)
                      (ADJP (JJ murine)))
                    (NN Btk) (NNS promoters))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP murBtkprom) (, ,) (NNP humBtkprom))
                    (-RRB- -RRB-))))))))
      (VP (VBD were)
        (NP
          (NP (VBN exposed) (NNS three-times))
          (ADJP (JJR longer)
            (PP (IN than)
              (NP
                (NP (NNS experiments))
                (SBAR
                  (WHADVP (WRB where))
                  (S
                    (NP (DT the) (JJ wild-type) (NN octamer))
                    (VP (VBD was)
                      (VP (VBN used)))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 3))
      (: :)
      (NP
        (NP (JJ Ternary) (NN complex) (NN formation))
        (PP (IN on)
          (NP (NN Btk) (NN promoter) (NN octamer) (NNS motifs))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN EMSA) (NNS experiments))
        (PP (IN with)
          (NP (NN HeLa) (JJ nuclear) (NNS extracts))))
      (VP (VBD were)
        (VP (VBN performed)
          (S
            (VP (VBG using)
              (NP
                (NP (VBN labeled) (NNS probes))
                (VP (VBG bearing)
                  (NP (CC either)
                    (NP
                      (NP (DT a) (NN consensus) (NN octamer) (NN motif))
                      (PRN (-LRB- -LRB-)
                        (NP (NN cons) (NN Oct) (NN site))
                        (-RRB- -RRB-)))
                    (CC or)
                    (NP
                      (NP (DT the) (NN octamer) (NNS sequences))
                      (VP (VBN identified)
                        (PP (IN within)
                          (NP
                            (NP (DT the)
                              (ADJP
                                (ADJP (JJ murine))
                                (CC or)
                                (ADJP (JJ human)))
                              (NN Btk) (NN promoter))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (NN Oct-hum) (NN Btk) (NN prom))
                                (, ,)
                                (NP (NN Oct-mur) (NN Btk) (NN prom)))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Unprogrammed) (NN reticulocyte) (NN lysate))
        (CC or)
        (NP
          (ADJP
            (ADVP (FW in) (FW vitro))
            (VBN translated))
          (NN BOB.1/OBF.1) (NN protein)))
      (VP (VBD were)
        (VP (VBN included))))
    (. .)))

(
  (S
    (S
      (NP (NNS Complexes))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN by)
            (S
              (VP (VBG adding)
                (NP (JJ specific) (NNS antibodies))
                (PP (IN for)
                  (NP
                    (NP
                      (NP (NN Oct1))
                      (, ,)
                      (NP (NN Oct2))
                      (CC or)
                      (NP (NN BOB.1/OBF.1)))
                    (SBAR (IN as)
                      (S
                        (VP (VBN indicated))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 4))
      (: :)
      (NP (NN ChIP) (NN assay)))
    (. .)))

(
  (S
    (S
      (NP (NN BOB.1/OBF.1))
      (VP (VBZ binds)
        (PP
          (ADVP (RB together))
          (IN with)
          (NP
            (NP (NN Oct1))
            (CC and)
            (NP (NN Oct2))))
        (PP (TO to)
          (NP (DT the) (JJ murine) (NN Btk) (NN promoter)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN chromatin))
        (PP (IN of)
          (NP (JJ primary) (JJ wild-type) (NN B) (NNS cells))))
      (VP (VBD was)
        (UCP
          (ADJP (JJ cross-linked))
          (, ,)
          (ADJP (JJ sheared))
          (CC and)
          (VP (VBN immunoprecipitated)
            (PP (IN with)
              (NP (DT the) (VBN indicated) (NNS antibodies)))))))
    (. .)))

(
  (S
    (S
      (NP (VBN Immunoprecipitated) (NN DNA))
      (VP (VBD was)
        (VP
          (VP (VBN purified))
          (CC and)
          (VP (VBN used)
            (PP (IN as)
              (NP (NN template)))
            (PP (IN in)
              (NP
                (NP (NN PCR))
                (PP (IN with)
                  (NP
                    (NP (NNS primers))
                    (ADJP (JJ specific)
                      (PP
                        (PP (IN for)
                          (NP
                            (NP (DT the) (JJ murine) (NN Btk) (NN promoter))
                            (PRN (-LRB- -LRB-)
                              (NP (CD −280) (TO to) (CD −10))
                              (-RRB- -RRB-))))
                        (, ,)
                        (CC or)
                        (PP (IN for)
                          (NP
                            (NP (DT the) (NN H2B)
                              (CC and)
                              (NN Pax5) (NNS promoters))
                            (PP (IN as)
                              (NP (JJ internal) (NNS controls)))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Chromatin))
        (VP (VBN immunoprecipitated)
          (PP (IN with)
            (NP
              (NP (NN anti-PLCγ1))
              (CC and)
              (NP (NN anti-Lyn))
              (NP (NNS antibodies))))))
      (VP (VBD was)
        (VP (VBN included)
          (PP (IN as)
            (NP (JJ negative) (NNS controls))))))
    (. .)))

(
  (S
    (S
      (NP (VBN Amplified) (NNS products))
      (VP (VBD were)
        (VP (VBN detected)
          (PP (IN on)
            (NP
              (NP (NN ethidium) (NN bromide))
              (VBN stained) (NN agarose) (NNS gels))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 5))
      (: :)
      (NP
        (NP (NN Analysis))
        (PP (IN of)
          (NP
            (NP (DT the) (NN dependence))
            (PP (IN of)
              (NP (DT the) (JJ murine) (NN Btk) (NN promoter) (NN activity)))
            (PP (IN on)
              (NP
                (NP
                  (NP (NN Oct))
                  (CC and)
                  (NP (NN BOB.1/OBF.1) (NNS proteins)))
                (PP (IN in)
                  (NP
                    (NP (JJ transient) (NN transfection) (NNS experiments))
                    (VP (VBG using)
                      (NP (NN NIH/3T3) (NNS fibroblasts))))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN Activity))
        (PP (IN of)
          (NP (DT the) (JJ murine) (NN Btk) (NN promoter)))
        (PP (IN without)
          (NP (NN co-transfection))))
      (VP (VBD was)
        (VP (VBN set)
          (PP (TO to)
            (NP (NN one))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ fold) (NN induction))
        (PP (IN upon)
          (NP
            (NP
              (NP (NN co-transfection))
              (PP (IN of)
                (NP
                  (NP (NN Oct2))
                  (, ,)
                  (NP (NN BOB.1/OBF.1))
                  (CC or)
                  (NP (NN PU.1)))))
            (CC or)
            (NP
              (NP (NNS combinations))
              (PP (IN of)
                (NP (DT these) (NN expression) (NNS vectors)))))))
      (VP (VBD was)
        (VP (VBN determined))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NNS experiments))
        (VP (VBD were)
          (VP (VBN repeated)
            (NP (CD five) (NNS times)))))
      (CC and)
      (S
        (NP
          (NP (JJ mean) (NNS values))
          (CONJP (RB as) (RB well) (IN as))
          (NP (NN SD)))
        (VP (VBD were)
          (VP (VBN determined)))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-))
      (NP (DT The) (JJ murine) (NN Btk) (NN promoter))
      (VP (VBZ is)
        (VP (VBN induced)
          (SBAR
            (WHADVP (WRB when))
            (S
              (NP
                (NP (NN Oct2))
                (CC and)
                (NP (NN BOB.1/OBF.1)))
              (VP (VBP are)
                (VP (VBN coexpressed))))))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS B) (-RRB- -RRB-))
      (NP
        (NP (DT The) (NN activation))
        (PP (IN of)
          (NP (DT the) (JJ murine) (NN Btk) (NN promoter)))
        (PP (IN by)
          (NP
            (NP (NN Oct2))
            (CC and)
            (NP (NN BOB.1/OBF.1)))))
      (VP (VBZ is)
        (ADJP (JJ dose-dependent))))
    (. .)))

(
  (S
    (NP
      (NP
        (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))
        (JJ Synergistic) (NN activation))
      (PP (IN of)
        (NP (DT the) (JJ murine) (NN Btk) (NN promoter)))
      (PP (IN by)
        (NP
          (NP (NN Oct2))
          (, ,)
          (NP (NN BOB.1/OBF.1))
          (, ,)
          (CC and)
          (NP (NN PU.1))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NN Figure) (CD 6))
        (: :)
        (NP (DT The) (JJ transcriptional) (NN coactivator) (NN BOB.1/OBF.1)))
      (VP (VBZ is)
        (ADJP (JJ critical)
          (PP (IN for)
            (NP (NN Btk) (NN expression)))
          (ADVP (FW in) (FW vivo)))))
    (. .)))

(
  (S
    (S
      (LST (-LRB- -LRB-) (LS A) (-RRB- -RRB-))
      (NP
        (NP (NNS Mutations))
        (PP (IN within)
          (NP
            (NP (DT the) (NN octamer) (NN motif))
            (PP (IN of)
              (NP (DT the) (JJ murine) (NN btk) (NN promoter))))))
      (VP (VBP lead)
        (PP (TO to)
          (NP
            (NP (DT a) (NN reduction))
            (PP (IN of)
              (NP (NN promoter) (NN activity)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ murine) (NN S194) (NN B) (NN cell) (NN line))
      (VP (VBD was)
        (VP (VBN transfected)
          (PP (IN with)
            (NP (CC either)
              (NP
                (NP (DT the) (JJ wild) (NN type))
                (PRN (-LRB- -LRB-)
                  (NP (NN murBtk) (NN pr))
                  (-RRB- -RRB-)))
              (CC or)
              (NP
                (NP (DT the) (JJ mutant) (NN Btk) (NN promoter))
                (PRN (-LRB- -LRB-)
                  (NP (NN mBtk) (NN pr) (NN Mut))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN activity))
        (PP (IN of)
          (NP (DT the) (JJ wild-type) (NN promoter))))
      (VP (VBD was)
        (VP (VBN set)
          (PP (TO to)
            (NP (CD 100) (NN %))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN activity))
        (PP (IN of)
          (NP (DT the) (JJ mutant) (NN Btk) (NN promoter))))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (JJ relative) (TO to)
            (NP (DT the) (JJ wild-type) (NN promoter) (NN activity))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NNS experiments))
        (VP (VBD were)
          (VP (VBN repeated)
            (NP (CD five) (NNS times)))))
      (CC and)
      (S
        (NP
          (NP (JJ mean) (NNS values))
          (CONJP (RB as) (RB well) (IN as))
          (NP (NN SD)))
        (VP (VBD were)
          (VP (VBN determined)))))
    (. .)))

(
  (S
    (NP
      (NP (-LRB- -LRB-) (NN B) (-RRB- -RRB-) (NN Protein) (NNS extracts))
      (PP (IN from)
        (NP
          (NP (NN pre) (NN B) (NN cell) (NNS lines))
          (VP (VBN established)
            (PP (IN from)
              (NP
                (NP (DT the) (NN bone) (NN marrow))
                (PP (IN of)
                  (NP
                    (NP (JJ wild) (NN type))
                    (CC or)
                    (NP (NN BOB.1/OBF.1−/−mice))))))))))))

(
  (S
    (S
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN for)
            (NP (NN Btk) (NN expression)))
          (PP (IN by)
            (NP (NN western) (NN blot))))))
    (. .)))

(
  (S
    (NP
      (NP
        (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))
        (NN RNA))
      (VP (VBN prepared)
        (PP (IN from)
          (NP
            (NP
              (ADJP
                (NP (NN bone) (NN marrow))
                (VBN derived))
              (NN pre) (NN B) (NN cell) (NNS lines))
            (, ,)
            (VP (VBN established)
              (PP (IN from)
                (NP
                  (NP (NNS mice))
                  (VP (VBG expressing)
                    (NP (DT a) (JJ conditional) (NN BOB.1/OBF.1) (NN transgene))
                    (PP (IN on)
                      (NP (DT a) (NN BOB.1/OBF.1-mutant)))))))))))))

(
  (S
    (S
      (NP
        (NP (NN background))
        (, ,))
      (VP (VBD was)
        (VP (VBN analyzed)
          (PP (IN for)
            (NP (NN Btk) (NN mRNA) (NN expression)))
          (PP (IN by)
            (NP (NN northern) (NN blot))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In) (DT the) (NN absence) (IN of)
          (NP
            (NP (NN Doxycyclin))
            (PRN (-LRB- -LRB-)
              (NP (NN Dox))
              (-RRB- -RRB-))))
        (NP (DT the) (JJ co-activator) (NN BOB.1/OBF.1))
        (VP (VBZ is)
          (VP (VBN expressed))))
      (, ,) (IN whereas)
      (S
        (PP (IN in) (DT the) (NN presence) (IN of)
          (NP (NN Dox)))
        (NP (PRP$ its) (NN expression))
        (VP (VBZ is)
          (VP (VBN repressed)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (-LRB- -LRB-) (NN D) (-RRB- -RRB-) (NN Protein) (NNS extracts))
        (VP (VBD were) (VBN prepared)
          (PP (IN from)
            (NP (VBN sorted) (NN B220+mice)))))
      (VP (VBD were)
        (VP (VBN analyzed)
          (PP (IN for)
            (NP (NN Btk) (NN expression)))
          (PP (IN by)
            (NP (NN western) (NN blot))))))
    (. .)))

(
  (S
    (NP
      (NP
        (LST (-LRB- -LRB-) (LS C) (-RRB- -RRB-))
        (NN RNA))
      (VP (VBN prepared)
        (PP (IN from)
          (NP
            (NP
              (ADJP
                (NP (NN bone) (NN marrow))
                (VBN derived))
              (NN pre) (NN B) (NN cell) (NNS lines))
            (, ,)
            (VP (VBN established)
              (PP (IN from)
                (NP
                  (NP (NNS mice))
                  (VP (VBG expressing)
                    (NP (DT a) (JJ conditional) (NN BOB.1/OBF.1) (NN transgene))
                    (PP (IN on)
                      (NP (DT a) (NN BOB.1/OBF.1-mutant)))))))))))))

(
  (S
    (S
      (NP
        (NP (NN background))
        (, ,))
      (VP (VBD was)
        (VP (VBN analyzed)
          (PP (IN for)
            (NP (NN Btk) (NN mRNA) (NN expression)))
          (PP (IN by)
            (NP (NN northern) (NN blot))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In) (DT the) (NN absence) (IN of)
          (NP
            (NP (NN Doxycyclin))
            (PRN (-LRB- -LRB-)
              (NP (NN Dox))
              (-RRB- -RRB-))))
        (NP (DT the) (JJ co-activator) (NN BOB.1/OBF.1))
        (VP (VBZ is)
          (VP (VBN expressed))))
      (, ,) (IN whereas)
      (S
        (PP (IN in) (DT the) (NN presence) (IN of)
          (NP (NN Dox)))
        (NP (PRP$ its) (NN expression))
        (VP (VBZ is)
          (VP (VBN repressed)))))
    (. .)))

(
  (S
    (LST (-LRB- -LRB-) (LS D) (-RRB- -RRB-))
    (NP (NN Protein) (NNS extracts))
    (VP (VBD were)
      (VP (VBN prepared)
        (PP (IN from)
          (NP
            (NP (VBN sorted) (NN B220+) (NNS splenocytes))
            (PP (IN from)
              (NP (CC either)
                (NP (JJ wild) (NN type))
                (CC or)
                (NP (NNS BOB.1/OBF.1−/−))))))))))

(
  (S
    (S
      (NP (NNS mice))
      (CC and)
      (VP (VBN analyzed)
        (PP (IN for)
          (NP (NN Btk) (NN expression)))))
    (. .)))

(
  (S
    (NP
      (NP
        (PRN (-LRB- -LRB-)
          (NP (NN E))
          (-RRB- -RRB-))
        (NN RNA))
      (VP (VBD was) (VBN prepared)
        (PP (IN from)
          (NP (NNS splenocytes)))
        (PP (IN from)
          (NP
            (NP (JJ wild) (NN type))
            (CC or)
            (NP (NN BOB.1/OBF.1−/−))))))))

(
  (S
    (S
      (NP
        (NP (NNS mice))
        (CC and)
        (NP (DT the) (NN Btk–mRNA) (NN expression)))
      (VP (VBD was)
        (VP (VBN analyzed)
          (PP (IN by)
            (NP (NN northern) (NN blot))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN RelA))
          (PRN (-LRB- -LRB-)
            (NP (NN p65))
            (-RRB- -RRB-)))
        (CC or)
        (NP (NNS GAPDH)))
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN as)
            (NP (NN loading) (NNS controls))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN WB))
        (VP (VBG =)
          (NP (NN western) (NN blot))))
      (: ;)
      (S
        (NP (NN NB))
        (VP (VBG =)
          (NP (NN northern) (NN blot)))))
    (. .)))

